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ABSTRACT
Australia’s Tobacco Plain Packaging Act 2011 (TPP) and
corresponding regulations specify that tobacco products be
packaged in a particular size box and be made of certain
material.2 No trademark other than the brand’s name may be
printed, and font, letter size, color, and other packaging aspects
are specified with particularity.3 These measures recently
withstood a contentious dispute settlement request submitted
on multiple grounds by four World Trade Organization (WTO)
Member countries.4 What does the WTO’s Panel Report in this
case tell us about the extent to which a country can take
measures to advance its public health initiatives without
violating obligations under Article 20 of the Agreement on
Trade-Related Aspects of Intellectual Property (TRIPS)? What
is the legal test for deciding this? To what extent can WTO
Members undertake broad policy initiatives with the objective of
protecting public health? Could WTO Members carry out these
initiatives even when the consequence is far-reaching
diminishment of branding and economic value of other Members’
trademark rights? Could the WTO Panel’s findings in this case
embolden countries to take similar action with other consumer
products medically proven to cause harm?

See generally Tobacco Plain Packaging Act 2011 (Cth) (Austl.)
[hereinafter TPP Act 2011]; WHO Framework Convention on Tobacco Control
May
21,
2003,
2301
U.N.T.S.
166,
available
at
http://whqlibdoc.who.int/publications/2003/9241591013.pdf (recognizing the
health, social, economic and environmental consequences of tobacco
consumption and exposure to tobacco smoke, WHO negotiated its first treaty
in 2003 and garnered 168 Signatories); for clarity, I will use the abbreviation
“TPP” to refer only to the Tobacco Plain Packaging Act 2011, and the term
“TPP measures” to include both the Act and corresponding regulations, this
phrasing is consistent with the WTO’s usage of these terms in Australia
Trademark Panel Report.
3 TPP Act 2011, supra note 2, ch 2 pt II div 1 sub-div 18.
4 See generally Panel Report, Australia — Certain Measures Concerning
Trademarks, Geographical Indications and Other Plain Packaging
Requirements Applicable to Tobacco Products and Packaging, WTO Doc.
WT/DS435/R; WT/DS441/R; WT/DS458/R; WT/DS467/R (adopted June 28,
2018) [hereinafter Australia Trademarks Panel Report] (showing
complainants are Honduras, the Dominican Republic, Cuba, and Indonesia,
respectively).
2
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This article examines and evaluates the arguments and
analysis of one of the primary grounds used to challenge
Australia’s plain packaging measures, Agreement on Trade
Related Aspects of Intellectual Property Rights (TRIPS) Article
20, which prohibits the unjustifiable encumbrance of
trademarks used in the course of trade through the imposition
of special requirements.5 After introducing the scope and
context of tobacco-related health, economic, and societal issues
worldwide, the article addresses Australia’s development and
passage of the Tobacco Plain Packaging measures. Next, Article
20 and its elements are discussed. As this was the first WTO
case to decide the parameters of permissible trademark special
requirements, the parties’ arguments and panel decision
relating to Article 20 are summarized and analyzed. The article
then reviews the key WTO Panel report’s legal determinations
and rationale, and then assesses whether similar trademark
restrictions could be applied to other potentially dangerous
products like alcohol and sugary, salty, or fatty foods without
violating Article 20. The conclusion considers legal and business
implications of the WTO Panel’s analysis of complainants’ failed
claim that Australia’s Tobacco Plain Packaging measures violate
TRIPS Article 20.
I. INTRODUCTION
A: Health and Social Effects of Tobacco Use
Tobacco-related illnesses are some of the biggest public
health threats in the history of the world6 According to the
World Health Organization (WHO), approximately every six
seconds, one person dies from a tobacco-caused disease.7 In
2017, deaths relating to tobacco use had risen to about 7.2
million people a year,8 and were forecasted to increase to more
5 Agreement on Trade Related Property Rights art. 20, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C,
1869 U.N.T.S.299 [hereinafter TRIPS].
6 News Release, World No Tobacco Day, 31 May 2016: Get ready for plain
packaging, World Health Org. (May 31, 2016) (on file with World Health
Organization) [hereinafter WHO World No Tobacco Day].
7 Id.
8 WORLD HEALTH ORG., WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC:
MONITORING TOBACCO USE AND PREVENTION POLICIES 17 (2017) [hereinafter
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than eight million people a year by 2030,9 exceeding HIV/AIDS,
tuberculosis and malaria combined.10 On average, tobacco users
lose 15 years of life.11
Tobacco use is one of the largest preventable causes of
noncommunicable diseases12 and is in fact “the only common risk
factor across all four major non-communicable diseases
(cardiovascular diseases, cancers, chronic respiratory diseases
and diabetes).”13 Contributing to the death, disability and
illness is the fact that, at least in recent years, “cigarettes and
some other products containing tobacco are highly engineered so
as to create and maintain dependence, and that many of the
compounds they contain and the smoke they produce are . . .
toxic, mutagenic and carcinogenic.”14 Smoking tobacco can
cause many forms of cancer, including “lung, larynx, lip, tongue,
mouth, pharynx, oesophagus, pancreas, bladder, kidney, cervix,
stomach and acute myeloid leukaemia, liver cancer, and urinary
tract cancer,”15 as well as “stroke, peripheral vascular disease,
chronic obstructive pulmonary disease, several serious
cardiovascular diseases, many kinds of respiratory diseases and
impairments and other types of disease.”16
Also, and
importantly, the scope of medical issues relating to tobacco is not
limited to smokers; significant harm can be caused to nonsmokers. Approximately 1.2 million non-smokers die annually
from illness related to second-hand smoke.17 Passive smoking
“causes premature death and disease in children and in adults
who do not smoke.”18 According to the WHO, “there is clear
WHO Report].
9 WHO World No Tobacco Day, supra note 6.
10 WHO Report, supra note 8.
11 World Health Org., Tobacco Threatens Us All 3 (2017) [hereinafter
WHO Tobacco Threatens Us All].
12 WHO World No Tobacco Day, supra note 6.
13 Australia Trademarks Panel Report, supra note 4, ¶ 7.2579.
14 World Health Organization [WHO], Framework Convention on Tobacco
Control, opened for signature June 16, 2003, 2302 U.N.T.S. 166 (entered into
force Feb. 27, 2005) [hereinafter WHO FCTC].
15 Australia Trademarks Panel Report, supra note 4, ¶ 7.2578.
16 Id.
17 Indu B. Ahluwalia, et. al., Tobacco Use and Tobacco-Related Behaviors
—11 Countries, 2008-2017, 68 MORBIDITY & MORTALITY WKLY. REP. 928, 928
(Oct.18, 2019).
18 Australia Trademarks Panel Report, supra note 4, ¶ 7.2578.
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scientific evidence that prenatal exposure to tobacco smoke
causes adverse health and developmental conditions for
children.”19 The evidence makes it clear why this is an urgent
public health problem based on medical data alone.
In addition to the human toll, tobacco “represents a major
barrier to sustainable development that impacts health, poverty,
global hunger, education, economic growth, gender equality, the
environment, finance and governance.”20 Money from medical
resource budgets is diverted from other pressing priorities.
Money from household budgets is diverted from basic
necessities. The cost of smoking is estimated at $1.4 trillion, or
1.8% of global Gross Domestic Product (GDP),21 with
corresponding annual global health care costs associated with
smoking being approximately $422 billion.22 The remaining cost
of about $1 trillion per year is indirect; for example, lost
productivity due to illness and premature death.23 To put this
in perspective, the annual cost of smoking globally is equal to
about ten times the amount spent on aid worldwide, or nearly
the GDP of Canada, the world’s tenth wealthiest country.24 This
social and economic impact continues even when smoking rates
decline because the disease and health effects caused by tobacco
consumption can take years to manifest.25
Tobacco usage contributes to poverty and impacts lowerincome countries which have fewer resources and less ability to
control and combat the problem. “The burden of death and
diseases from non-communicable diseases is most heavily
concentrated in the world’s poorest countries.”26 More than 80%
of tobacco-related deaths occur in low- and middle-income
countries.27 According to Dr. Vera Luiza da Costa e Silva, head
of WHO’s convention secretariat, “[t]he epicentre of this
19
20
21
22
23
24
25
26
27

WHO FCTC, supra note 14, at 1.
WHO Tobacco Threatens Us All, supra note 11, at 2.
Id.
Id. at 3.
Id.
Id.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2580.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2579.
WHO World No Tobacco Day, supra note 6.
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epidemic has moved to the developing world, where low- and
middle-income countries struggle to combat a tobacco industry
seeking to pursue new markets, often through shameless
interference with public health policymaking.”28 Moreover,
vulnerable populations and disadvantaged communities are
disproportionately impacted.29 The WHO warns that smoking is
starting at increasingly early ages;30 tobacco consumption by
women and young girls has been increasing;31 and tobacco
consumption by indigenous peoples remains high.32
Even in higher-income countries, lower-income people are
disproportionately impacted. For example, in Australia, tobacco
smoking accounts for “12.1% of the total burden of disease and
20% of deaths among Aboriginal and Torres Strait Islander
peoples.”33
Moreover, there are adverse environmental impacts.
According to the WHO, “[t]obacco smoke emissions also
contribute thousands of tonnes of human carcinogens, toxicants
and greenhouse gases to the environment.”34 It also contributes
to deforestation. For every 300 cigarettes produced, one tree is
lost.35 Waste discarded from cigarette consumption totals up to
680,000 tons globally per year.36 Tackling tobacco control is
evidently not easy. Tobacco companies spend staggering sums
of money to retain and expand their market.
United
States (U.S.) Congressional findings forming the basis of the
Family Smoking Prevention and Tobacco Control Act (TCA)
noted that “[i]n 2005, the cigarette manufacturers spent more
than $13,000,000,000 to attract new users, retain current users,
increase current consumption, and generate favorable long-term
attitudes toward smoking and tobacco use.”37 ”According to the
WHO Report, supra note 8, at 17.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2580.
30 WHO FCTC, supra note 14, at 1.
31 Id.
32 Id. at 2.
33 Australia Trademarks Panel Report, supra note 4, ¶ 7.2580.
34 WHO Tobacco Threatens Us All, supra note 11, at 6.
35 Id.
36 Id.
37 Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 11131, 123 Stat. 1776 (2009) [hereinafter TCA].
28
29
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[U.S.] [Federal Trade Commission], tobacco companies spent
approximately $12.49 billion on advertising and promotion in
2006 alone, employing marketing and advertising experts to
incorporate current trends and target their messages toward
certain demographics.”38
B. Responses by the WHO and Governmental Tobacco Control
and Smoking Reduction Initiatives, generally
The World Health Organization labels the tobacco problem
as an “epidemic.”39 In fact, in the preamble to its Framework
Convention on Tobacco Control (FCTC), the WHO describes the
“tobacco epidemic” as “a global problem with serious
consequences for public health that calls for the widest possible
international cooperation and the participation of all countries
in an effective, appropriate and comprehensive international
response” and cites the “devastating worldwide health, social,
economic and environmental consequences of tobacco
consumption and exposure to tobacco smoke.”40 For the WHO,
tobacco control was such a high priority that it was the subject
of the first convention it ever concluded, in May 2003, taking
effect in 2005.41 In this landmark initiative, the FCTC
constructs a two-pronged strategy of decreasing tobacco usage
through reducing both demand and supply.
The core demand-reduction provisions in the WHO FCTC are
contained in articles 6-14:


Price and tax measures . . . ; and



Non-price measures to reduce the demand for tobacco,
namely:


Protection from exposure to tobacco smoke;



Regulation of contents of tobacco products;



Regulation of tobacco product disclosures;



Packaging and labelling of tobacco products;

38 R.J. Reynolds Tobacco Co. v. Food & Drug Admin., 696 F.3d 1205, 1221
(D.C. Cir. 2012).
39 WHO FCTC, supra note 14, at 1.
40 Id.
41 Id. at v–vi.
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Education, communication, training and public
awareness;



Tobacco advertising, promotion and sponsorship;
and



Demand reduction measures concerning tobacco
dependence and cessation.

The core supply-reduction provisions in the WHO FCTC are
contained in articles 15-17:


Illicit trade in tobacco products;



Sales to and by minors; and



Provision of support for economically viable alternative
activities.42

Of note, for purposes of this article is the pledge that
signatories include large, clear, rotating health warnings on 50%
(or, at least, 30%) of the principal display area on the package.43
The WHO’s subsequent Guidelines for Implementation of Article
11 of the WHO Framework Convention on Tobacco Control
(Packaging and Labelling of Tobacco Products) specifically
encourages the adoption of plain packaging: “[p]arties should
consider adopting measures to restrict or prohibit the use of
logos, colours, brand images or promotional information on
packaging other than brand names and product names
displayed in a standard colour and font style (plain
packaging).”44 The Guidelines for the Implementation of Article
13 of the WHO Framework Convention on Tobacco Control
describes plain packaging as:
[B]lack and white or two other contrasting colours, as prescribed
by national authorities; nothing other than a brand name, a
product name and/or manufacturer’s name, contact details and the
quantity of product in the packaging, without any logos or other
features apart from health warnings, tax stamps and other
government-mandated information or markings; prescribed font

Id. at v.
Id. at 11.
44 Guidelines for implementation of Article 11 of the WHO Framework
Convention on Tobacco Control (Packaging and Labelling of Tobacco Products),
¶ 46, WHO Doc. FCTC/COP3(10) (Nov. 2008).
42
43
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style and size; and standardized shape, size and materials. There
should be no advertising or promotion inside or attached to the
package or on individual cigarettes or other tobacco products.45

In part based on the WHO’s international efforts and the
widespread adoption of the FCTC,46 individual countries (and
sometimes states, provinces, and municipalities) have developed
strategies and implemented policies aimed at reducing smoking
levels.47 Governments have tackled tobacco control with varying
levels of urgency, focus, effort, commitment, and support. Some
countries and regions have adopted far-reaching and sometimes
creative tobacco control measures. In 2014, partly to meet its
FCTC obligations, the European Union introduced the broadranging Tobacco Products Directive (TPD),48 which brought
Guidelines for implementation of Article 13, Tobacco advertising,
promotion and sponsorship, ¶ 16, WHO Doc. FCTC/COP3(12) (Nov. 2008); see
also Susy Frankel & Daniel Gervais, Plain Packaging and the Interpretation
of the TRIPS Agreement, 46 VAND. J. OF TRANSNAT’L L. 1149, 1163 (2013)
(emphasizing a noncommittal aspect of this FCTC provision stating “[l]egally
speaking, no FCTC member has an obligation to apply any of [FCTC]
Guidelines, nor do those Guidelines amend any of the WTO instruments . . . it
seems self-evident that though they are contextually relevant, the Guidelines
do not amount to a deletion of TRIPS Agreement obligations.”).
46 Parties to the WHO Framework Convention on Tobacco Control, WORLD
HEALTH ORG., https://www.who.int/fctc/signatories_parties/en/ (last updated
Nov. 23, 2017) (noting between its adoption in May 2003 and the closure if the
Convention signature period in June 2004, 168 states signed the FCTC;
currently, there are 181 member states).
47 See Thomas Bollyky & David Fidler, Has a Global Tobacco Treaty Made
a
Difference?,
THE
ATLANTIC
(Feb.
28,
2015)
https://www.
theatlantic.com/health/archive/2015/02/has-a-global-tobacco-treaty-made-adifference/386399/ (“A decade later, it is clear that the FCTC, on its own, was
insufficient to generate improved tobacco control in low- and middle-income
countries, but has been a contributing factor in the recent progress that has
occurred.”). But see Lorraine Craig et. al., Impact of the WHO FCTC on Tobacco
Control: Perspectives from Stakeholders in 12 Countries, 28 TOBACCO CONTROL
129, 134 (2019) (“[I]n its first decade, the FCTC has had significant impacts on
tobacco control according to stakeholders in each of the 12 mission countries.
Stakeholders were unanimous in the view that without the Treaty, tobacco
control would not have advanced to the extent it had at the time of the
interviews. The FCTC has elevated tobacco control as a public health priority
in the national and international agendas, and provided a best practice
roadmap and mechanisms to support evidence-based action on tobacco within
a supporting legally binding framework.”).
48 Directive 2014/40, of the European Parliament and of the Council of 3
April 2014 on the approximation of the
laws, regulations and administrative provisions of the Member States
concerning the manufacture, presentation and
45
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major changes to tobacco marketing. At the time the TPD
became effective, Dr. Martina Pötschke-Langer, Head of Unit
Cancer Prevention WHO Collaborating Centre for Tobacco
Control, German Cancer Research Center, said, “[t]he past two
years have been an intense time for those of us working in
tobacco control. The European Commission has adopted nine
legal acts . . . containing the detailed technical rules needed to
implement the TPD [including] . . . the appearance of the new
health warnings.”49
Presumably to help curtail smoking by young people, in
March, 2019, the WHO urged governments “to implement their
domestic laws banning tobacco advertising, promotion and
sponsorship in the strongest possible ways. This may include
issuing penalties applicable under domestic laws and taking
preventative action, such as by preventing screening of events
that violate domestic laws.”50 It also urged enforcement of bans
on tobacco advertising at sporting events51 and international
exhibitions.52
Other countries restrict tobacco products, marketing and
distribution less severely than the European Union, sometimes
falling short of FCTC guidelines. In the United States, the Food
and Drug Administration (FDA) has had the authority to
regulate tobacco products since the passage of the TCA in 2009.53
sale of tobacco and related products and Repealing Council Directive
2001/37/EC, 2014 O.J. (L 127) 1, 1–38.
49 Dr. Martina Pötschke-Langer, The Tobacco Products Directive –
Implementation in the EU, HEALTH-EU (Eur. Commission) May 26, 2016.
50 WHO urges governments to enforce bans on tobacco advertising,
promotion, and sponsorship, including in motor sport, WORLD HEALTH ORG.
(Mar. 14, 2019), https://www.who.int/news-room/detail/14-03-2019-who-urgesgovernments-to-enforce-bans-on-tobacco-advertising-promotion-andsponsorship-including-in-motor-sport.
51 Id.
52 WHO statement urging governments to ban tobacco advertising,
promotion, and sponsorship at international expositions, WORLD HEALTH ORG.
(Aug.15,
2019),
https://www.who.int/news-room/detail/15-08-2019-whostatement-urging-governments-to-ban-tobacco-advertising-promotion-andsponsorship-at-international-expositions.
53 TCA, supra note 37, at 1776; see, e.g., Micah L. Berman, The Faltering
Promise of FDA Tobacco Regulation, 12 ST. LOUIS U. J. HEALTH L. & POL’Y 145,
145 (2018) (debating the effectiveness of the FDA’s efforts to control tobacco
usage under the TCA).
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Ten years later, the FDA announced a “Comprehensive Plan for
Tobacco and Nicotine Regulation”54 which proposed regulation
of nicotine levels, increasing use of medicinal products to assist
in quitting smoking, public education campaign, addressing
vaping safety and more.55 It also covered revision of warning
labels—not
surprisingly,
since
“[i]n
the
U.S.,
cigarette packages still have the small, text-only warnings that
have been on the side of cigarette packages since 1965.”56 The
FDA was instructed to issue regulations concerning graphic
warning labels on certain tobacco products within two years of
the TCA’s enactment,57 which resulted in the eventual proposal
of nine images to pair with the nine textual warnings outlined
in the statute.58 However, when the FDA was challenged by R.J.
Reynolds Tobacco Company on First Amendment grounds, the
U.S. Court of Appeals for the District of Columbia upheld
summary judgment in favor of the Tobacco Company, vacated
the graphic warning requirements, and remanded to the FDA.59
On January 30, 2020, the FDA again attempted to require
graphic warnings on cigarette packaging by proposing “13 . . .
warnings, which feature text statements accompanied by photorealistic color images depicting some of the lesser-known health
risks of cigarette smoking, [which] stand to represent the most
significant change to cigarette labels in 35 years.”60 In South
54 FDA’s Comprehensive Plan for Nicotine and Tobacco Regulation, U.S.
FOOD & DRUG ADMIN., https://www.fda.gov/tobacco-products/ctp-newsroom
/fdas-comprehensive-plan-tobacco-and-nicotine-regulation (last visited Mar.
28, 2020).
55 Id.
56 Berman, supra note 53, at 153.
57 See TCA, supra note 37, 1845 (“Not later than 24 months after the date
of enactment of the Family Smoking Prevention and Tobacco Control Act, the
Secretary shall issue regulations that require color graphics depicting the
negative health consequences of smoking . . . . The Secretary may adjust the
type size, text and format of the label statements [as previously] specified . . .
as the Secretary determines appropriate so that both the graphics and the
accompanying label statements are clear, conspicuous, legible and appear
within the specified area”).
58 See Required Warnings for Cigarette Packages and Advertisements, 76
Fed. Reg. 36639 (June 22, 2011) (to be codified at 21 C.F.R. pt.1141) (listing
the nine warning labels to be produced on tobacco products).
59 R.J. Reynolds Tobacco Co. v. Food & Drug Admin., 696 F.3d 1205, 1208
(D.C. Cir. 2012).
60 Cigarette Health Warnings, U.S. FOOD & DRUG ADMIN., https://www
.fda.gov/tobacco-products/labeling-and-warning-statements-tobaccoproducts/cigarette-health-warnings (last visited Mar. 28, 2020).
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Africa, also a signatory to the FCTC, tobacco advertising and
promotion is severely limited as smoking can be restricted in
both public and workplace areas and text-only health warnings
are required.61 Nevertheless, tobacco excise taxes fall far short
of the WHO’s recommendation that excise tax account for 70%
of retail prices.62
Approximately 120 countries have adopted graphic
warnings labels for cigarette packages, starting with Canada in
2000.63 As a result, the number of people living in countries that
have introduced tobacco control measures quadrupled between
2009 and 2019, to a total of 5 billion people.64 Warnings have
been a prominent part of these measures in many countries. As
of September 2018, “107 countries/jurisdictions have required
warnings to cover at least 50% of the package front and back (on
average), up from 94 in 2016 and 24 in 2008 [and t]here are now
55 countries/jurisdictions with a size of at least 65% (on average)
of the package front and back.”65
C. History, Background and Context of Australia’s Tobacco
Plain Packaging Act
In June of 2009, Australia’s Preventative Health Taskforce
unveiled its report, “Australia: The Healthiest Country by 2020”
a National Preventative Health Strategy.66 The report provided
61 South Africa Tobacco Control Policies, CAMPAIGN TOBACCO-FREE KIDS,
https://www.tobaccocontrollaws.org/legislation/factsheet_pdf/policy_status/so
uth-africa (last visited Mar. 28, 2020).
62 Id.
63 Associated Press, U.S. makes new push for graphic warning labels on
cigarettes, NBC NEWS (Aug. 15, 2019, 2:41 PM), https://www.nbcnews.
com/health/health-news/us-makes-new-push-graphic-warning-labelscigarettes-n1042866.
64 WHO launches new report on the global tobacco epidemic, WORLD
HEALTH ORG., (July 26, 2019), https://www.who.int/news-room/detail/26-072019-who-launches-new-report-on-the-global-tobacco-epidemic; see generally
Tobacco Control Laws, CAMPAIGN TOBACCO-FREE KIDS, https://www.
tobaccocontrollaws.org/ (providing an excellent overview of tobacco control
legislation and litigation all over the world) (last visited Mar. 28, 2020).
65 CANADIAN CANCER SOCIETY, CIGARETTE PACKAGE HEALTH WARNINGS:
INTERNATIONAL STATUS REPORT 2 (6th ed. 2018).
66 NAT’L PREVENTATIVE HEALTH TASKFORCE, AUSTRALIA: THE HEALTHIEST
COUNTRY BY 2020 17–19 (June 30, 2009) [hereinafter Nat’l Preventative Health
Taskforce].
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a roadmap which lists and describes actions to achieve the
ambitious goal of becoming the world’s healthiest country by
2020.67
Tobacco control is featured prominently (not
surprisingly) in this report. Further, the report provides that,
in Australia, tobacco use remains one of the leading causes of
preventable disease and premature death and that as many as
two in three Australian smokers will die prematurely from
smoking-related diseases.68 The report also discusses that
smokers in Australia are twice as likely as non-smokers to have
been diagnosed or treated for a mental illness.69 According to
the Australian Government Department of Health, smoking
killed about 19,000 Australians in 2011.70 The taskforce report
included eleven “key action areas” related to tobacco control.71
These key action areas ranged from increasing tobacco costs to
raising the intensity and reach of both social marketing and
public awareness campaigns to eliminating second-hand smoke
in public places.72 It also recommended boosting efforts to
reduce and discourage smoking among young people, indigenous
Australians, and disadvantaged groups.73 Importantly, it is
within this far-reaching plan that the task force also included
recommendations specific to the marketing and advertising of
tobacco products.74 Under the heading “Tobacco,” action items 3
and 5, respectively, state:
3. End all remaining forms of advertising and promotion of tobacco
products.


Legislate to eliminate all remaining forms of tobacco
promotion, including, as feasible, through new and
emerging forms of media



Amend legislation nationally and in all states and

Id. at 6–7.
Australia Trademarks Panel Report, supra note 4, at ¶ 7.2578
(referencing paragraphs 1 and 28–30 of Australia’s first written submission).
69 Id. ¶ 7.1318.
70 National Tobacco Campaign,
AUSTL. GOV’T DEP’T OF HEALTH,
https://www.health.gov.au/initiatives-and-programs/national-tobaccocampaign (last updated Dec. 24, 2019).
71 Nat’l Preventative Health Taskforce, supra note 66, at 12–25.
72 Id.
73 Id. at 37–38.
74 Id.at 33–34.
67
68
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territories to ensure that tobacco is out-of-sight in retail
outlets


Eliminate the promotion of tobacco products through
design of packaging


Amend Tobacco Advertising Prohibition Act 1992
to require that no tobacco product may be sold
except in packaging of a shape, size, material and
colour prescribed by government.



Amend
Trade
Practices
CPIS
(Tobacco)
Regulations 2004 to specify exact requirements for
plain packaging

...
5. Regulate manufacturing and further regulate packaging and
supply of tobacco products


Improve consumer information related to tobacco products


Mandate standard plain packaging of all tobacco
products to ensure that design features of the pack
in no way reduce the prominence or impact of
prescribed government warnings



Automatically review and upgrade warnings on
tobacco packages at least every three years, with
the Chief Medical Officer to have the capacity to
require amendments and issue additional
warnings of new and emerging risks in between.



Tighten and enforce legislation to eliminate sales to
minors and any form of promotion at retail level.



Give government power to regulate design, contents and
maximum emissions for tobacco and related products, and
establish a regulatory body with responsibility for
specifying required disclosure to government, labelling
and any other communication to consumers



Investigate the feasibility of legal action by governments
and others against tobacco companies75

On April 29, 2010, the Australian Government announced
measures to ““deliver on [the] recommendations of the
75

Id. at 17–18.
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[NPHT]”“76 including increasing tobacco excise by 25%; enacting
legislation to require that all cigarettes be sold in plain
packaging by 1 July 2012; restricting Australian internet
advertising of tobacco products; and spending more on antismoking campaigns.77 Ultimately, this led to implementation of
a comprehensive range of Australian tobacco control measures,
“including advertising and promotional bans, excise measures,
graphic health warnings, and investments in anti-smoking
initiatives.”78
This also lead to tobacco plain packaging
79
measures. A defensive strategy was employed to combat the
realities of the tobacco industry’s marketing. As Professor
Andrew Mitchell of Melbourne Law School explains, cigarette
companies invest heavily in packaging and brand name design
in part because “approximately half of smokers cannot
distinguish between similar cigarettes”80 and therefore
“packaging is necessary for product differentiation.”81 He notes
the particular importance of packaging “in ‘dark’ markets, such
as Australia, where tobacco advertising is banned”82 since fewer
marketing distribution channels mean pressure to utilize fully
the sole remaining possibility, the product package itself.
D. Australia’s Tobacco Plain Packaging Act 2011,
corresponding regulation and challenges in Australian court
Pursuant to NPHT recommendations and with the goal of
giving effect to its obligations under the FCTC, the Australian
Parliament passed the Tobacco Plain Packaging Act 2011

Australia Trademarks Panel Report, supra note 4, ¶ 2.8.
Id.
78 Id. ¶ 7.2581.
79 INTERGOVERNMENTAL COMM. ON DRUGS, NATIONAL TOBACCO STRATEGY
2012-2018 iii (2012) (identifying Australia’s continued prioritization of
controlling tobacco use in nine areas: protect public health policies from
tobacco industry interference; eliminate the remaining advertising, promotion
and sponsorship of tobacco products; reduce the affordability of tobacco
products; increase smoke-free areas; strengthening mass media and public
education campaigns; improving access to evidence-based cessation services;
and considering further regulation of tobacco contents, disclosure and supply).
80 Andrew Mitchell, Australia’s Move to the Plain Packaging of Cigarettes
and its WTO Compatibility, 5 ASIAN J. OF WTO & INT’L HEALTH L. & POL’Y 399,
401, 401–02 (2010).
81 Id. at 402.
82 Id. at 402.
76
77
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(TPP).83 As of December 1, 2012, all tobacco products sold,
offered for sale, or otherwise supplied in Australia were required
to comply with TPP.84 The Act states:
(1) The objects of this Act are:
(a) to improve public health by:
(i) discouraging people from taking up smoking, or
using tobacco products; and
(ii) encouraging people to give up smoking, and to
stop using tobacco products; and
(iii) discouraging people who have given up smoking,
or who have stopped using tobacco products, from
relapsing; and
(iv) reducing people’s exposure to smoke from tobacco
products; and
(b) to give effect to certain obligations that Australia has as
a party to the Convention on Tobacco Control.
(2) It is the intention of the Parliament to contribute to achieving
the objects in subsection (1) by regulating the retail packaging and
appearance of tobacco products in order to:
(a) reduce the appeal of tobacco products to consumers; and
(b) increase the effectiveness of health warnings on the
retail packaging of tobacco products; and
(c) reduce the ability of the retail packaging of tobacco
products to mislead consumers about the harmful effects of
smoking or using tobacco products.85

In its subsequent defense when challenged at the WTO,
Australia asserted that important purposes of the Act where to
“limit the ability of the pack to distract from and reduce the
noticeability of GHWs [graphic health warnings]; prevent
tobacco companies from using different colours to create
misleading perception of the harmful effects of tobacco use or to
exploit certain positive associations with particular colours; and,

See TTP Act 2011, supra note 2.
Id. (different sections of the Act became effective at different times, with
all provisions becoming effective by December, 2012).
85 Id. ch 1 pt I div 3.
83
84
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more broadly, to denormalize tobacco.”86
Under the Act, these objectives are accomplished by
stripping the packaging of essentially all trademark features
except the tradename. TPP measures detail comprehensive
specifications for all aspects of cigarette packages. Decorative
ridges or irregularities of shape or texture and colored glues and
adhesives are not permitted.87 The dimensions of cigarette
packs are specified:88 the opening of the pack must be flip-top;89
the material must be made only of rigid cardboard;90 the shape
must be rectangular91 and without embellishment;92 only foilbacked paper lining is permitted;93 and unless otherwise
permitted, the pack must have a “matte finish” of “drab dark
brown.”94 No variations for the shape, material, or texture of the
package are permitted.95 In effect, the cigarette package must
be stripped of all colors, logos, textures, and other branding. The
display of the product name is also strictly controlled.96 The
brand name must appear in the prescribed font, size and
placement on the package.97 In addition, health warnings and
graphic images are required to be included on the product’s
package.98
A detailed description of domestic challenges to the TPP are
beyond the scope of this paper, except to note briefly that failed
challenges to TPP on constitutional grounds were raised by four
tobacco companies in JT International SA v. Commonwealth of

Australia Trademarks Panel Report, supra note 4, ¶ 7.2476.
TPP Act 2011, supra note 2, ch 2 pt II div 1 sub-div 18 para 1.
88 Id. ch 2 pt II div 1 sub-div 18 para 1; see also Tobacco Plain Packaging
Regulations 2011 (Cth) pt II div 2 sub-div 1 (Austl.) (determining the
“[p]hysical features of retail packaging”) [hereinafter TPP Regulations 2011].
89 TPP Act 2011, supra note 2, ch 2 pt II div 1 sub-div 18 para 3.
90 Id. ch 2 pt II div 1 sub-div 18 para 2.
91 Id.
92 Id. ch 2 pt II div 1 sub-div 18 para 1.
93 Id. ch 2 pt II div 1 sub-div 18 para 3 (stating “must comply”).
94 Id. ch 2 pt II div 1 sub-div 19 para 2.
95 See TPP Act 2011, supra note 2, ch 2 pt 2 div 1 sub-div 18 para 3 (stating
“must comply”).
96 Id. ch 2 pt II div 1 sub-div 26.
97 TPP Regulations 2011, supra note 88, pt II div 2 sub-div 4 para 1.
98 TPP Act 2011, supra note 2, ch 2 pt II div 1 sub-div 21.
86
87
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Australia99 and British American Tobacco Australasia Limited
v. The Commonwealth.100 These cases were consolidated and
ultimately brought to the High Court of Australia. As explained
by Jonathan Liberman, Director of the McCabe Centre for Law
and Cancer:
The case was decided in the Australian Government’s favor on the
basis of the majority’s affirmation (six-to-one) of what Justices
Hayne and Bell described as the “bedrock principle” that “[T]here
can be no acquisition of property without ‘the Commonwealth or
another acquir[ing] an interest in property, however slight or
insubstantial it may be.’” ”[T]he relevant constitutional question
is whether there has been an acquisition of property, not whether
there has been a taking.” The tobacco companies were unable to
show any such acquisition. Arguments by the tobacco companies
that there need be no acquisition of “property” or of a benefit or
advantage of a proprietary nature ”sought to depart from [the]
bedrock principle.”101

II. CHALLENGES TO AUSTRALIA’S TPP MEASURES AT THE WORLD
TRADE ORGANIZATION
A. Public Health/World Trade tension, conflict, background
Domestic legal challenges aside, the case challenging TPP
measures raises interesting questions about conflicts and
tensions between public health policy and law on one hand and
world trade policy and law on the other. To start, the Agreement
on Trade Related Aspects of Intellectual Property Rights
(TRIPS) recognizes the importance of prioritizing public
health.102 TRIPS Article 8.1 (under the title General Provisions
and Basic Principles) states: “[m]embers may, in formulating or
amending their laws and regulations, adopt measures necessary
to protect public health and nutrition, and to promote the public
interest in sectors of vital importance to their socio-economic and
technological development, provided that such measures are
JT Int’l SA v Commonwealth [2012] HCA 43 (Austl.).
See id. (consolidating opinion with JT Int’l SA v Commonwealth).
101 Jonathan Liberman, Plainly Constitutional: The Upholding of Plain
Tobacco Packaging by the High Court of Australia, 39 AM. J. L. & MED. 361,
370–71 (2013).
102 See generally TRIPS, supra note 5.
99

100
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consistent with the provisions of this Agreement.”103 Later, the
Declaration on the TRIPS Agreement and Public Health, adopted
by the WTO on November 14, 2001, specifically states, “[w]e
agree that the TRIPS Agreement does not and should not
prevent Members from taking measures to protect public
health . . . . [W]e affirm that the Agreement can and should be
interpreted and implemented in a manner supportive of WTO
Members’ right to protect public health.”104 Numerous WTO
panel decisions and Appellate Body decisions acknowledge and
support deference to health measures and the promotion of
public health over promotion of international trade.105
B. WTO Dispute Settlement, overview and procedural
background
On April 4, 2012, Honduras requested consultations at the
WTO with Australia, challenging Australia’s TPP measures.106
Subsequently, the Dominican Republic, Cuba, and Indonesia
joined in requesting consultations with Australia on this matter,
with several other countries requesting to participate in the
proceedings as third parties.107
The complaints were
consolidated into Dispute Settlement 435, wherein
complainants advanced multiple legal challenges to Australia’s
TPP measures, asserting violations of several provisions of
TRIPS, the Technical Barriers to Trade Agreement (TBT) and
the General Agreement on Tariffs and Trade (GATT).108
Id. pt I art. 8.1.
World Trade Organization, Declaration on the TRIPS agreement and
public health of 14 November 2001, WTO Doc. WT/MIN(01)/DEC/2, 4 ILM 746
(2002) [hereinafter Doha Declaration].
105 See, e.g., Appellate Body, United States – Standards for Reformulated
and Conventional Gasoline, WTO Doc. WT/DS2/AB/R (adopted May 20, 1996)
[hereinafter US – Gasoline] (affirming GATT Article XX’s provision to permit
important state interests, including the protection of human health); see also
Appellate Body, European Communities – Measures Affecting Asbestos and
Asbestos-Containing Products, WTO Doc. WT/DS135/AB/R (adopted Apr. 5,
2001) (discussing in Section VII Article XX(b) of the GATT 1994 and Article 11
of the DSU, specifically referring to the issue of protecting human life or
health).
106 Australia Trademarks Panel Report, supra note 4, ¶ 1.1.
107 Id. ¶¶ 1.19, 1.23.
108 Id. ¶¶ 7.3.5.2.1–7.3.5.2.3 (specifically, complainants alleged the
following violations: 1. Article 2.1 of the Technical Barriers to Trade
Agreement, claiming Australia’s PP regulations accord to imported tobacco
103
104
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The resulting Panel Report, issued June 28, 2018, spans 888
pages and provides detailed reviews of the complainants’
respondents’ and third parties’ arguments, as well as the panel’s
rationale and decision for all eleven treaty provision violations
alleged.109 For purposes of this article, only TRIPS Article 20 is
examined. The language of Article 20 itself (stating “[t]he use of
a trademark in the course of trade shall not be unjustifiably
encumbered by special requirements”) embodies the essential
tension between health policy and trademark rights.110 Several
of the other provisions that the complainants allege were
violated are important, but they are more technical and
arguably less demonstrative of the health policy versus the
trademark rights dispute.
products treatment less favorable than that accorded to like products of
national origin; 2. Article 2.2 of the TBT Agreement, claiming Australia’s PP
regulations create unnecessary obstacles to trade because they are more traderestrictive than necessary to fulfill a legitimate objective; 3. Article 2.1 of the
TRIPS Agreement, in particular, (i) Article 6quinquies of the Paris Convention,
because trademarks registered in a country of origin outside Australia are not
protected “as is”; and, (ii) Article 10bis of the Paris Convention, because
Australia does not provide effective protection against unfair competition, for
example, creating confusion between the goods of competitors; 4. Article 3.1 of
the TRIPS Agreement, claiming Australia accords to nationals of other
Members treatment less favorable than it accords to its own nationals with
respect to the protection of intellectual property; 5. Article 15.4 of the TRIPS
Agreement, claiming nature of the goods to which a trademark is to be applied
forms an obstacle to the registration of the trademark; 6. Article 16.1 of the
TRIPS Agreement, claiming the measures prevent owners of registered
trademarks from enjoying the rights conferred by a trademark; 7. Article 16.3
of the TRIPS Agreement, claiming the measures prevent owners of registered
trademarks that are “well known” from enjoying the rights conferred by a
trademark; 8. Article 20 of the TRIPS Agreement, claiming the use of
trademarks in relation to tobacco products is unjustifiably encumbered by
special requirements, such as (i) use in a special form, for example, the uniform
typeface, font, size, color, and placement of the brand name, and, (ii) use in a
manner detrimental to the trademark’s capability to distinguish tobacco
products of one undertaking from tobacco products of other undertakings; 9.
Article 22.2(b) of the TRIPS Agreement, because Australia does not provide
effective protection against acts of unfair competition with respect to
geographical indications, for example, creating confusion among consumers
with respect to the origin of goods; 10. Article 24.3 of the TRIPS Agreement,
because Australia is diminishing the level of protection it affords to
geographical indications as compared with the level of protection that existed
prior to 1 January 1995; and 11. Article III:4 of the GATT 1994, because the
measures at issue accord to imported tobacco products treatment less favorable
than that accorded to like products of national origin).
109 See generally id.
110 TRIPS, supra note 5, art. 20.
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C. Trademarks under TRIPS, generally
There has been much discussion (and confusion) regarding
the nature of trademark rights under WTO rules and the extent
to which countries must extend trademark protection. A good
starting point is TRIPS Article 16, which states:
The owner of a registered trademark shall have the exclusive right
to prevent all third parties not having the owner’s consent from
using in the course of trade identical or similar signs for goods or
services which are identical or similar to those in respect of which
the trademark is registered where such use would result in a
likelihood of confusion. In case of the use of an identical sign for
identical goods or services, a likelihood of confusion shall be
presumed. The rights described above shall not prejudice any
existing prior rights, nor shall they affect the possibility of
Members making rights available on the basis of use.111

Appellate Reports and Panel Reports have helped illustrate
and explain the nature of these exclusive rights.112 In United
States Section 211 Omnibus Appropriations Act of 1998, the
appellate body agreed with a previous panel report that “the
definition of the conditions of [trademark] ownership has been
left to the legislative discretion of individual countries of the
Paris Union by Article 6(1) of the Paris Convention (1967).”113
The appellate body opined that once trademark ownership is
established, “Article 16 confers on the owner of a registered
trademark an internationally agreed minimum level of
‘exclusive rights’ that all WTO Members must guarantee in their
domestic legislation. These exclusive rights protect the owner
against infringement of the registered trademark by
unauthorized third parties.”114
While the right of exclusivity for a registered trademark
owner is established, the right of exploitation is not guaranteed.

Id. art. 16.
See supra note 108.
113 Appellate Body Report, United States – Section 211 Omnibus
Appropriations Act of 1998, ¶ 189, WTO Doc. WT/DS176/AB/R (adopted Feb.
1, 2002).
114 Id. ¶ 186.
111
112
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Some scholars, like Professor Mark Davison of Monash
University, maintain that TRIPS Article 16 “only confers a right
to prevent others using a trademark,”115 but does not confer a
right to use a trademark. This is consistent with the Panel
Report in European Communities — Protection of Trademarks
and Geographical Indications for Agricultural Products and
Foodstuffs which stated:
[T]he TRIPS Agreement does not generally provide for the grant
of positive rights to exploit or use certain subject matter, but
rather provides for the grant of negative rights to prevent certain
acts. This fundamental feature of intellectual property protection
inherently grants Members freedom to pursue legitimate public
policy objectives since many measures to attain those public policy
objectives lie outside the scope of intellectual property rights and
do not require an exception under the TRIPS Agreement.116

Presumably then, businesses from WTO Member countries
do not have the inherent right to have or to use a trademark in
another Member country.
However, if they register a
(presumably valid) trademark, they must be granted a minimal
level of exclusive rights. Here, “exclusive rights” means the
business is the only one granted the rights and may, as a
corollary, exclude others from infringing on the rights.117
D. Panel’s analysis of Article 20 claims and rationale for their
decision
As noted above, this article focuses on the allegation that
TPP measures violate TRIPS Article 20, which is only one of
several violations alleged in the requests for dispute resolution.
115 Mark Davison, Why the TRIPS Challenges to Plain Packaging Will
Fail,
MCCABE
CENTRE,
http://www.mccabecentre.org/downloads/
M_Davison_TRIPS_for_website_word_format_-_1.pdf.
116 Panel Report, European Communities – Protection of Trademarks and
Geographical Indications for Agricultural Products and Foodstuffs, ¶ 7.210,
WTO Doc. WT/DS174/R (adopted Apr. 20, 2005) [hereinafter EC –
Geographical Indications].
117 See Mark Davison & Patrick Emerton, Rights, Privileges, Legitimate
Interests and Justifiability: Article 20 of TRIPS and Plain Packaging of
Tobacco, 29 AM. U. INT’L. L. REV. 505, 518–19, 541, 547 (2014) (addressing the
questions of whether TRIPS article 20 creates a privilege, right of use, or a
negative right).
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Article 20 states that:
The use of a trademark in the course of trade shall not be
unjustifiably encumbered by special requirements, such as use
with another trademark, use in a special form or use in a manner
detrimental to its capability to distinguish the goods or services of
one undertaking from those of other undertakings. This will not
preclude a requirement prescribing the use of the trademark
identifying the undertaking producing the goods or services along
with, but without linking it to, the trademark distinguishing the
specific goods or services in question of that undertaking. 118

Regarding Article 20 specifically, the EC – Geographical
Indications panel stated Article 20 does “not preclude a
requirement prescribing the use of [a] trademark” in a certain
way,119 nor does it address the issue of exclusivity.120 The
question remains as to when prescribing the use of a trademark
in a certain way is within the boundaries of Article 20.
At the outset of its Article 20 analysis, the Panel reviewed
and decided the issue of burden of proof.121 The parties agreed
that the complainants were required to establish a prima facie
case that the TPP measures constituted “special requirements
that encumber the use of trademarks in the course of trade
within the meaning of Article 20.”122 Still, they disagreed as to
whether the complainants or Australia bore the burden of
proving the justifiability of encumbrances within the scope of
Article 20.123 Justifiability of encumbrances would prove to be,
as argued later in this article, the key issue of contention and of
importance in this case.124
Complainants and third-party Members posed, inter alia,
the following arguments in favor of Australia bearing the burden
of proving relevant special requirements were justified. First,
the structure of Article 20’s language (“use . . . shall not be
118
119
120
121
122
123
124

TRIPS, supra note 5, art. 20.
Id.
Id.
Australia Trademarks Panel Report, supra note 4, ¶¶ 7.2151–7.2171.
Id. ¶ 7.2161.
Id. ¶ 7.2162.
See infra Part 2(D)(iii).

https://digitalcommons.pace.edu/pilr/vol32/iss2/2

24

2020

PACE INT’L L. REV.

271

unjustifiably encumbered”125) implies a presumption in favor of
the unencumbered use of trademarks through special
requirements since unencumbered trademarks are the normal
default. Any encumbrance of the use of a trademark through
special requirements “triggers the obligation to ensure that any
such [obligation] is justifiable.”126 Second, the prohibitive aspect
of Article 20 is being qualified through the word “unjustifiably.”
As such, “the complainant bears the initial burden of
demonstrating the prohibitive aspect of the provision (i.e. that a
measure involves an encumbrance on use by special
requirements); thereafter, the burden of demonstrating that the
encumbrance is justifiable shifts to the respondent.”127 Third,
requiring that the Member ensure an encumbrance is justifiable
“is consistent with the ordinary meaning of the term ‘justifiable’,
which means ‘defensible’ . . . because the ordinary meaning of
this term suggests that it is the defendant who bears the burden
of ‘justifying’ a measure that falls within . . . Article 20.”128
Fourth, it is incorrect for a complainant “to identify and refute a
justification which it may be unaware of or which it may not be
able to particulari[z]e.”129 Fifth, and finally, Article 20
establishes a general prohibition on the use of special
requirements, and prior WTO panel decisions support the view
that “a party invoking an exception or an affirmative defence
bears the burden of proof.”130
Australia and others agreed that the burden of proof rests
with the party (whether complaining or defending) who “asserts
the affirmative of a particular claim or defence.”131 However,
Australia argued, nothing in the TRIPS Agreement requires
Members to confer trademark use to a fellow Member.
Therefore, Article 20 is not in fact an “exception,” so the use of
TRIPS, supra note 5, art. 20.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2135.
127 Id. ¶ 7.2141.
128 Id. ¶ 7.2140.
129 Id. ¶ 7.2142; see also Frankel & Gervais, supra note 45, at 1210
(arguing that normally, the complainant has the burden of proof, but because
the complainant is not the party who relies on a domestic policy reasons for the
encumbrance, the respondent carries the burden to show that the
encumbrance is justified).
130 Australia Trademarks Panel Report, supra note 4, ¶ 7.2144.
131 Id. ¶ 7.2145.
125
126
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special requirements does not carry with it the burden of proving
any corresponding encumbrances are justified.132 In essence,
there is no right to use a trademark, so Article 20 is not, in fact,
a prohibition with an exception. Therefore, the complainants
bear the burden of proving all elements of their prima facie case,
including the element of unjustifiability.133 In resolving this
issue, the Dispute Panel relied on the Appellate Body’s previous
endorsement of the principle that “the party asserting a fact,
whether complainant or respondent, is responsible for providing
proof thereof” and that “[t]he burden of proof rests upon the
party . . . who asserts the affirmative of a particular claim or
defence.”134 The Dispute Panel expressly rejected the claim that
Article 20’s text or grammatical structure implies that there is a
“default situation” of unencumbered trademark use, causing
Australia to bear the burden of showing “justifiability.”135
Referencing previous Appellate Body decisions relevant to this
question, the Panel noted that other similarly worded provisions
containing “negative” formulations have not been interpreted as
placing a burden of proof on the defendant in connection with
interpreting the Technical Barriers to Trade Treaty (TBT)136 or
in the context of the Agreement on the Application of Sanitary
and Phytosanitary Measures (SPS Agreement).137 The Panel
concluded that “it is for the complainants to present a prima
facie case that the TPP measures amount to special
requirements and that the use of a trademark in the course of

Id. ¶ 7.2146.
Id. ¶ 7.2151.
134 Id. ¶ 7.2158 (citing Appellate Body Report, United States – Measures
Affecting Imports of Woven Wool Shirts and Blouses from India, WTO Doc.
WT/DS33/AB/R (adopted May 23, 1997)).
135 Id. ¶ 7.2163.
136 Australia Trademarks Panel Report, supra note 4, ¶ 7.2165 (citing
Appellate Body Reports, United States – Certain Country of Origin Labelling
(COOL) Requirements, ¶ 379, WTO Doc. WT/DS384/AB/R (adopted May 29,
2015); and Appellate Body Report, United States – Measures Concerning the
Importation, Marketing and Sale of Tuna and Tuna Products, ¶ 323,
WT/DS381/AB/RW (adopted Jan. 11, 2019)).
137 Id. ¶ 7.2168 (quoting Appellate Body Report, European Communities –
Measures Concerning Meat and Meat Products (Hormones),¶ 109,
WT/DS26/AB/R (adopted Feb. 13, 1998) stating: “it was the complainant’s task
to present evidence and legal arguments sufficient to demonstrate a violation
of the obligations contained in each specific relevant provision of [the
Agreement]”)).
132
133
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trade is unjustifiably encumbered by these requirements.”138
Having established the threshold burden of proof question,
the Panel then broke its analysis into three parts, each of which
will be examined in detail: first, whether TPP measures involve
“special requirements” that “encumber” the use of a trademark;
second, whether the special requirements in the TPP measures
encumber the “use of a trademark” “in the course of trade;” and
third, whether the TPP measures “unjustifiably” encumber the
use of trademarks in the course of trade.139
1. Whether TPP measures involve “special requirements” that
“encumber” the use of a trademark (7.3.5.3)
Are Australia’s TPP measures “special requirements”? If so,
do those requirements “encumber” use of cigarette trademarks?
Neither “special requirement” nor “unjustifiably encumber” are
defined in the TRIPS agreement.
a. Meaning of “special requirements”
Australia agreed there was no question the TPP measures
constituted special requirements, at least in some respects, but
that the scope of the special requirements is at issue.140 One
area of dispute related to the extent to which prohibitions on the
use of a trademark are “special requirements” within the
meaning of Article 20. Australia’s position was that a country
may prohibit the use of a trademark altogether under TRIPS.141
Article 19 provides in relevant part that “[c]ircumstances arising
independently of the will of the owner of the trademark which
constitute an obstacle to the use of the trademark, such as
import restrictions on or other government requirements for
goods or services protected by the trademark, shall be recognized
as valid reasons for non-use.”142 In Australia’s view, the rights
Members are required to confer under TRIPS are negative rights
of exclusion, not a right to a trademark.143 When trademark use
138
139
140
141
142
143

Id. ¶ 7.2169.
Id. ¶ 7.2172.
Id. ¶ 7.2138.
Id. ¶ 7.2187.
TRIPS, supra note 5, art. 19.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2188.
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is permissible, Article 20 is concerned with special requirements
imposed on trademark use.144 As a result, in Australia’s view,
Article 20 refers to “how a trademark may be used when it is
used, not to whether it can be used.”145 If domestic law bans the
use of certain trademarks, then “those trademarks are not being
‘use[d] . . . in the course of trade’ and Article 20 is therefore not
engaged.”146 Under complainants’ interpretations, Australia
argues, tobacco control measures in common use among WTO
Members, such as prohibitions on tobacco print and broadcast
advertising, would fall under Article 20’s scope.147
In response, Indonesia asserted that “Australia’s
interpretation would create an untenable situation where the
TRIPS Agreement would allow Members total freedom to impose
a prohibition on the use of a trademark without justification or
explanation, but would be required to provide a justification and
explanation when imposing limitation on the use of a
trademark.”148 Indonesia argued that Australia’s concern that a
country’s ability to ban a product could fall within the scope of
Article 20, thereby undermining other tobacco-control policies,
is flawed because:
[T]here is a distinction between a general prohibition on the
availability of a good and a prohibition on the use of a specific
trademark or a special class of trademarks on a good that is
lawfully placed on the market. Article 20 is not concerned with
the application of any and all requirements that may indirectly
encumber the use of trademarks. Rather, it addresses the
application of “special requirements.” A general prohibition, such
as on the sale of a good in the market or on advertising generally,
does not satisfy the definition of a “special requirement” on the use
of a trademark.149

Id. ¶ 7.2187.
Id. ¶ 7.2185.
146 Id. ¶ 7.2225.
147 Id. ¶ 7.2189.
148 Id. ¶ 7.2202; see also id. ¶ 7.2194 (noting the Dominican Republic made
a similar point in arguing that a prohibition on use of a trademark would
clearly be an encumbrance and that it would make no sense to permit a
Member to severely encumber a trademark to the point of defeating its
function, yet require a Member to justify a weak form of encumbrance).
149 Australia Trademarks Panel Report, supra note 4, ¶ 7.2203.
144
145
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Rather, Article 20 does not apply to advertising bans or
restrictions on availability of a product. It applies to “legal
conditions directly regulating the trademark itself.”150
The Panel rejected Australia’s argument insofar as it
refused to link governments’ ability to prevent trademark use in
Article 19 with whether such a ban constitutes a “special
requirement” under Article 20. The Panel stated that “[t]he fact
that Article 19 contemplates the existence of a government
measure that prevents the use of a trademark . . . does not, as
such, address whether any such measure would amount to a
special requirement affecting the use of a trademark and be
subject to the disciplines of Article 20.”151
On the question of the exact meaning of “special
requirements” that encumber use of a trademark in the course
of trade, both parties and non-parties advanced very different
interpretations. Even those parties on the same side of the
dispute interpreted “special requirements” differently. For
example, Honduras submitted that a “special requirement” in
the context of Article 20 means “measures of a compulsory
nature that are exceptional, address distinctive elements of a
trademark, or are limited in their application to particular
aspects of trademarks or their use.”152 The Dominican Republic
argued that a “special requirement” is a condition mandated by
the government and is unusual either because “it prescribes ‘use’
of a trademark in a manner that departs from the usual
treatment of a trademark; or . . . it applies to trademarks used
in connection with a particular type of good or service; or . . .
both.”153 In Cuba’s estimation, the requirements were “‘special’
because they affect only trademarks used on tobacco
products.”154 Indonesia argued that “‘special requirements’ are
‘mandated requirements that: 1) apply to a limited product class;
2) apply only for a particular purpose; or 3) are distinct from

150
151
152
153
154

Id. ¶ 7.2196.
Id. ¶ 7.2230.
Id. ¶ 7.2176.
Id. ¶ 7.2179.
Id. ¶ 7.2181.
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those that apply generally or ‘usually’.”155 Under any of these
interpretations, TPP measures would be considered special
requirements.
To understand the meaning of the term “special
requirements” in the context of Article 20, the Panel determined
that “the term ‘requirements’ is broad in scope.”156 The Panel
referenced the Oxford English Dictionary entry definition of
“requirement” as “‘[s]omething called for or demanded; a
condition which must be complied with.’”157 A “requirement”
could be permitting or banning “a certain action.”158 The Panel
also determined that the term “special” suggests two
connotations: the first “‘[h]aving a close or exclusive connection
with a specified person [or] thing[;]’” and the second, “being
‘[e]xceptional in quality or degree; unusual; out of the
ordinary.’”159
The Panel then concluded this issue by deciding similarly to
Honduras’ position noted above in stating:
[T]he term “special requirements” refers to a condition that must
be complied with, has a close connection with or specifically
addresses the “use of a trademark in the course of trade”, and is
limited in application. This may include a requirement not to do
something, in particular a prohibition on using a trademark. 160

b. Meaning of “encumbrance”
Next, the Panel frames the question “for the purposes of
determining whether ‘special requirements’ may be considered
to ‘encumber the use of a trademark’, [the relevant question] is
not whether the trademark is being used, but rather whether its
use is being encumbered by the ‘special requirements’ at

Australia Trademarks Panel Report, supra note 4, ¶ 7.2183.
Id. ¶ 7.2222 (quoting Panel Report, European Communities – Measures
Affecting the Approval and Marketing of Biotech Products, WTO Doc.
WT/DS291/R (adopted Nov. 21, 2006) [hereinafter EC – Biotech Products]).
157 Id.
158 Id. (relying on EC – Biotech Products).
159 Id. ¶ 7.2223.
160 Id. ¶ 7.2231.
155
156
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issue.”161
Disputing Australia’s position, the Panel opined as follows:
[W]e see no basis for assuming that a “special requirement”
prohibiting entirely the use of a trademark would not “hinder” or
“hamper” the use of such trademark . . . if the use of a trademark
is prohibited, it is “encumbered” to the greatest possible extent.
We are therefore not persuaded that the terms of Article 20 imply
that only “special requirements” that would determine how a
trademark may be used . . . may be considered to “encumber the
use” of such trademark.”162

In essentially concurring with Indonesia’s argument, the
Panel agrees that Australia’s position is “‘counterintuitive’ . . .
[in that] a measure that restricts the use of a trademark would
be subject to . . . Article 20 while a more far-reaching measure to
prohibit such use would not.”163
The Panel concluded that “the requirements of the TPP
measures permitting the use of word marks on tobacco retail
packaging . . . constitute ‘special requirements’ within the
meaning of Article 20.”164 The Panel further concluded that “[i]t
is also not in dispute that these requirements ‘encumber’ the use
of the affected trademarks, in that they restrict the manner in
which the trademarks at issue may be displayed on the relevant
products and their packaging.”165 The Panel finally stated: “[w]e
therefore agree with the parties that these measures affecting
word marks amount to ‘special requirements’ that ‘encumber’
the use of trademarks.”166

161

added).
162
163
164
165
166

Australia Trademarks Panel Report, supra note 4, ¶ 7.2232 (emphasis
Id. ¶ 7.2236.
Id. ¶ 7.2238.
Id. ¶ 7.2241.
Id. ¶ 7.2242.
Id. ¶ 7.2242.
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2. Whether the special requirements in the TPP measures
encumber the “use of a trademark” “in the course of trade”
(7.3.5.4)
a. Meaning of “in the course of trade”
The meaning of “in the course of trade” again elicited a
diversion of interpretations. Adopting a narrow reading of the
phrase, Australia argued that “course of trade” refers to acts
taken during the buying and selling of goods for profit and that
“an encumbrance is only relevant under Article 20 insofar as it
encumbers the use of a trademark while the trademarked
product remains within the course of trade, which . . .
culminates at the point of sale.”167 In short, “course of trade”
means while the trademarked product is being literally traded.
All complainants and third parties interpreted “course of
trade” more broadly than Australia did. At one end, Honduras
interpreted the phrase as capturing all activities related or
linked to trade including “all activities that have a connection
with, or a bearing on, trade, including for instance,
transportation, distribution, display, sale, use, as well as
advertising.”168 Slightly narrower in scope, the Dominican
Republic interpreted “course of trade” as “the succession of
events undertaken in producing, supplying, distributing, selling
and delivering goods and services for commercial purposes.”169
Cuba asserted that trademarks are used to distinguish products
from the perspective of consumers and commercial actors, and
because they are relevant to buying and selling decisions of those
actors, they are in the “course of trade.”170 Indonesia asserts
that “the course of trade” refers to activities conducted in a
commercial context as opposed to private use and as such, does
not end at the point of sale.171 The European Union found
Australia’s position too narrow because it excludes trademarks
used in advertising, catalogues, and the like. To be used in the
course of trade, “the mark must be used publicly and outwardly
167
168
169
170
171

Australia Trademarks Panel Report, supra note 4, ¶ 7.2252.
Id. ¶ 7.2248.
Id. ¶ 7.2249.
Id. ¶ 7.2250.
Id. ¶ 7.2251.
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in the context of commercial activity with a view to economic
advantage for the purpose of ensuring an outlet for the goods
and services which it represents.”172
Again disagreeing with Australia, the panel decided that
“the course of trade” does not specifically terminate or relate to
the point of sale or divide pre- and post-sale situations,173 noting
that in the ordinary meaning of the phrase, course of trade is not
limited to buying and selling, but rather, it “more broadly covers
the process relating to commercial activities.”174 Therefore, in
the context of Article 20, “in the course of trade” does not
culminate at the point of sale.175
b. Meaning of “use of a trademark”
Again, employing a narrow interpretation, Australia argued
that the use of a trademark is functional only: to distinguish
goods and services from those of other sources. As such, Article
20 does not cover special requirements which encumber the use
of a trademark for other reasons, such as to convey positive
associations with a product or to market to particular segments
of consumers.176 According to Australia, “[t]he use of a
trademark to advertise and promote . . . is not part of the
distinguishing function of a trademark” since the tradename
alone is sufficient to identify the source.177 In support, Australia
pointed to the definition of “protectable subject matter” in TRIPS
Article 15.1, which is “‘[a]ny sign, or any combination of signs,
capable of distinguishing the goods or services of one
undertaking from those of other undertakings, shall be capable
of constituting a trademark’.”178 Because trademarks used to
advertise and promote products fall outside the distinguishing
function, they fall outside the purview of Article 20.

172
173
174
175
176
177
178

Id. ¶ 7.2258.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2263.
Id. ¶ 7.2261.
Id. ¶ 7.2264.
Id. ¶ 7.2265.
Id. ¶ 7.2267.
Id. ¶ 7.2266.

33

280

Australia’s Tobacco Plain Packaging Law

Vol. 32:2

Not surprisingly, complainants opposed this view as too
limiting.
Honduras, for example, asserted that TRIPS
protection is not limited to only those elements Members think
are necessary to distinguish the products, but also covers other
protection, like figurative elements, that are capable of
distinguishing products.179 “There is no basis in the TRIPS
Agreement or in international [Intellectual Property] law
generally for asserting that word marks distinguish products in
a neutral manner [without marketing, promotion, etc.] whereas
figurative elements do not.”180 The Dominican Republic asserted
that interpretation of the phrase “the use of a trademark is
encumbered” does not require that the encumbrance on use
prevent the identification of the commercial source.181
Again, the Panel did not adopt Australia’s position and
defined “use of a trademark” closer to the complainants’ views.
The Panel determined that Article 20’s language is broad and
does not qualify the “use” in any particular way other than being
in the “course of trade.”182 Also, the definition of protectable
subject-matter provided in Article 15.1 does not imply any
limitation on the types of uses that are relevant to Article 20.183
In conclusion, “the relevant ‘use’ for the purposes of Article 20 is
not limited to the use of a trademark for the specific purpose of
distinguishing the goods and services of one undertaking from
those of other undertakings.”184 As applied to the TPP dispute,
the Panel finds that TPP measures affect the use of trademarks
“‘in the course of trade’, even within the narrow meaning given
to this term by Australia”185 and “amount to special
requirements that encumber ‘the use of a trademark in the
course of trade[.]’”186

Australia Trademarks Panel Report, supra note 4, ¶ 7.2272.
Id. ¶ 7.2273.
181 Id. ¶ 7.2276.
182 Id. ¶ 7.2280.
183 Id. ¶ 7.2283 (defining “protectable subject matter” as “[a]ny sign or
combination of signs capable of distinguishing the goods or services of one
undertaking from those of other undertakings”).
184 Id. ¶ 7.2286.
185 Australia Trademarks Panel Report, supra note 4, ¶ 7.2288.
186 Id. ¶ 7.2292.
179
180
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3. Whether the TPP measures “unjustifiably” encumber the
use of trademarks in the course of trade (7.3.5.5)
At the heart of the dispute between complainants and
Australia lies the disagreement over whether TPP measures are
an unjustifiable encumbrance. No prior panel has considered
the meaning of “unjustifiable” in the context of Article 20.187
Some legal scholars, like Professor Andrew Mitchell and
University of Melbourne Law School, correctly predicted in
advance of the panel’s decision that “[i]f it is established that
Article 20 applies, the main issue is whether the special
requirement encumbrance can be justified.”188 This raises a
critical question, which is how should a Dispute Resolution
Panel evaluate whether the measures are unjustifiable?
To begin, no party in the case disputes that the pursuit of
public health is a legitimate objective (articulated in TRIPS
Article 8.1, noted above).189 However, as Nicaragua asserted,
although public health is a legitimate policy objective that “does
not mean that any measure taken in furtherance of public health
is ‘justifiable.’”190 When pursuing an indisputably legitimate
objective, to what extent can a Member encumber the trademark
rights of another Member? What factors are considered when
determining whether the use of a trademark in the course of
trade is being unjustifiably encumbered by special
requirements? The following are the positions advanced by
complainants and respondents in framing how “unjustifiably”
should be decided.
a. Meaning of term “unjustifiably”
Public health objectives, in Honduras’ view, must be
balanced against Members’ obligation to ensure intellectual
property rights of fellow Members.191 Achieving this objective
Id. ¶ 7.2328 (noting the panel found that Australia states the term
“unjustifiable” has not been considered by the panel and the Appellate Body in
the context of Art. 20 but has been considered in other contexts).
188 Mitchell, supra note 80, at 412.
189 See supra note 103.
190 Australia Trademarks Panel Report, supra note 4, ¶ 7.2372.
191 Id. ¶ 7.2305 (noting that Honduras extends this by stating that if the
relevant measures consist of “blanket and indiscriminate restrictions on the
187
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rests on a determination of whether the measure “(i) makes a
material contribution to the public policy objective; and (ii)
constitutes the least-restrictive means to achieve this objective
among other options that are reasonably available.”192
In a similar approach, the Dominican Republic advanced a
legal standard which involves balancing the following four
factors: the nature and extent of the encumbrance; the objective
the Member seeks to achieve; whether the encumbrance
contributes to the objective; and whether less-restrictive
alternative measures could have been equally effective.193 In
balancing these interests, the Dominican Republic asserted that
Article 20 aims to “safeguard[] . . . to the greatest extent
possible, the ability of a trademark to fulfil its basic function of
distinguishing goods or services, without prejudicing the ability
of a Member to achieve other legitimate objectives.”194 Cuba
submitted that a special requirement is unjustifiable if the
objective is illegitimate; the special requirement is ineffective in
achieving its objective; or if the special requirement is
disproportionate because alternative measures are less of an
encumbrance. In this case, Cuba argued that TPP measures are
unjustifiable because they are ineffective or because they are
disproportionate.195 Indonesia supported a sliding scale where
“measures that impose a high degree of encumbrance also
impose a higher burden on the respondent to justify the
measure.”196
Based on previous panel and Appellate Body decisions
interpreting the word “unjustifiably” in other contexts, Australia
contended “that the use of a trademark in the course of trade is
‘unjustifiably’ encumbered by special requirements only if there
is no ‘rational connection’ between the imposition of the special
requirements and a legitimate public policy objective.”197
use of trademarks” or defeat the core function of a trademark, then no further
inquiry is necessary and the measures are unjustifiable under Article 20).
192 Id. (referencing Honduras’s first written submission, para. 315 and
Honduras’s second written submission, paras. 361–72).
193 Id. ¶ 7.2311.
194 Id. ¶ 7.2313.
195 Id. ¶ 7.2319.
196 Australia Trademarks Panel Report, supra note 4, ¶ 7.2324.
197 Id. ¶ 7.2329 (citing Australia’s first written submission, para. 369 and
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According to Australia, the relevant inquiry is “whether the
complainants have shown that the relationship between the
encumbrance imposed by the measure and the measure’s
objective is not one that is within the range of rational or
reasonable outcomes.”198 “Interpreting the term ‘unjustifiably’
to include a requirement of ‘least restrictiveness’ would render
this term functionally equivalent to a standard of ‘necessity’.”199
Returning to its position that TRIPS ensures negative rights but
not positive ones, Australia argued, in essence, that
complainants’ arguments rest on a right of use, but TRIPS does
not confer a right of trademark use.200
In Australia’s view, “the fact that the TRIPS Agreement
requires Members to confer certain negative rights of exclusion
upon IP owners ‘inherently grants Members freedom to pursue
legitimate public policy objectives’, since most measures that
regulate the use or exploitation of IP will not interfere with the
rights of exclusion that Members are required to confer.”201
At the heart of the case is the issue of the meaning and
implications of the term “unjustifiably.” The panel noted that:
The parties have discussed extensively the implications of the use
of the term “unjustifiably” in Article 20 on the nature and extent
of the relationship that must exist between, on one hand,
encumbrances on the use of trademarks resulting from the special
requirements at issue and, on the other, the reasons for which
these special requirements were adopted, or, in other words, how
it should be determined whether these reasons are sufficient to
support, and provide a justification for, the encumbrance resulting
from the special requirements.202

Fundamentally, two other TRIPS provisions relate to the
issue of justifiability, Article 8, quoted previously in this article,
and Article 7. Article 7, titled “Objectives,” provides that:
noting Australia’s response to Panel question No. 107).
198 Id. ¶ 7.2330 (citing Australia’s second written submission, para. 149).
199 Id. ¶ 7.2333.
200 Id. ¶ 7.2340.
201 Id. ¶ 7.2345.
202 Australia Trademarks Panel Report, supra note 4, ¶ 7.2412.
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The protection and enforcement of intellectual property rights
should contribute to the promotion of technological innovation and
to the transfer and dissemination of technology, to the mutual
advantage of producers and users of technological knowledge and
in a manner conducive to social and economic welfare, and to a
balance of rights and obligations.203

The panel noted that Article 8 contextualizes the term
“unjustifiably” in Article 20 and acknowledges the legitimacy of
certain reasons for encumbering trademark use, including
pursuing certain legitimate societal interests.204
In formulating a test for determining whether something is
unjustifiable in Article 20 cases, the panel rejected Australia’s
claim that “the use of a trademark is ‘unjustifiably’ encumbered
only if there is no rational connection between the imposition of
the special requirements and a legitimate public policy
objective.”205 Australia rested its argument on its interpretation
of Brazil – Retreaded Tyres, which, Australia claimed supported
the view that “the use of a trademark is ‘unjustifiably’
encumbered only if there is no rational connection between the
imposition of the special requirements and a legitimate public
policy objective.”206 However, the panel noted that it does not
follow that whenever some degree of rational connection does
exist, this would always be “sufficient to justify the
discrimination at issue.”207 Importantly, “the use of the term
‘unjustifiably’ conveys a requirement that encumbrances . . . be
capable of being explained, and that a justification or reason
should exist that sufficiently supports the encumbrance
resulting from the action or measure at issue.”208 This involves
some degree of rational explanation, but the existence of just any
rational connection will not always be sufficient to support the

TRIPS, supra note 5, art. 7.
Australia Trademarks Panel Report, supra note 4, ¶¶ 7.2404, 2.2405.
205 Id. ¶ 7.2420.
206 Id. ¶ 7.2420 (referencing the summary of Australia’s arguments in
paras. 7.2328 and 7.2329).
207 Id. ¶ 7.2421.
208 Id. ¶ 7.2422.
203
204
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imposition of the encumbrance permissible under Article 20.209
Upon rejecting Australia’s position advancing the rational
connection argument, the panel articulated the following test:
[W]hether the use of a trademark in the course of trade is being
“unjustifiably” encumbered by special requirements should
involve a consideration of the following factors:
a. the nature and extent of the encumbrance resulting from
the special requirements, bearing in mind the legitimate interest
of the trademark owner in using the trademark in the course of
trade and thereby allowing the trademark to fulfil its intended
function;
b. the reasons for which the special requirements are
applied, including any societal interests they are intended to
safeguard; and
c. whether these reasons provide sufficient support for the
resulting encumbrance.210

The panel specifically avoided determining how exactly the
interests should be weighed and balanced; instead, the panel
opined that such an assessment should be carried out on a caseby-case basis.211
b. Are the TPP measures per se unjustifiable?
Before applying the 3-part test, the Panel considered the
threshold claims argued by all four complainants that the TPP
measures are per se unjustifiable; therefore, the 3-part test need
not apply.212 Complainants advance four different reasons why
TPP measures are per se unjustifiable, thereby obviating the
need for further analysis and rendering the application of a
balancing analysis described above unnecessary.213

209
210

added).
211
212
213

Id.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2430 (emphasis
Id. ¶ 7.2431.
Id. ¶¶ 7.2433, 7.2434.
Id. ¶ 7.2433.
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The Panel addressed four arguments in turn. First,
Honduras and Indonesia argued that the extreme nature of
the encumbrance, specifically the prohibition on the use of
stylized work marks, figurative marks, and composite marks
rises to a level of restrictiveness that cannot be justified.214 On
this issue, the panel concluded that:
While a prohibition on use of a trademark by nature involves a
high degree of encumbrance on such use, we see no basis for
assuming that a particular threshold or degree of encumbrance
would be inherently “unjustifiable” under this provision. Rather,
we consider that this must in all cases be assessed in light of the
circumstances in accordance with the standard of review that we
have identified above.215

Second, all four complainants argued that TPP measures
are unjustifiable because Australia did not assess the
justifiability of the requirements in respect of individual
trademarks and their individual features.216 Of the four
arguments advanced in support of per se unjustifiability, the
most contested question was:
[W]hether Article 20 requires the “unjustifiability” of any “special
requirements” imposed on the use of trademarks to be assessed . . .
in relation to each individual trademark and its specific features
and whether . . . the encumbrances imposed by the TPP measures
are per se “unjustifiable” in that they do not involve such an
individual assessment but rather apply to all trademarks on
tobacco products without distinction. 217

In essence, complainants argued that Australia should have
separately considered each individual design feature of a
trademark, such as typeface, size, color, etc.,218 and that each
type of special requirement and its related encumbrance must
be evaluated and justified independently.219 Honduras argued
214
215
216
217
218
219

Id. ¶ 7.2434.
Id. ¶ 7.2441.
Australia Trademarks Panel Report, supra note 4, at ¶ 7.2434.
Id. ¶ 7.2492.
Id. ¶ 7.2462.
Id. ¶ 7.2465.
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that since trademarks are “examined and approved on an
individual basis and exist as individual trademarks,”220
encumbrances cannot “apply to a broad range of trademarks in
an indiscriminate manner.”221 The Dominican Republic argued
that trademark protection is individualized in terms of content,
acquisition, enjoyment, and enforcement of rights.222 As a
result, if a Member seeks to encumber the use of a trademark
through special requirements, it must take appropriate account
of the individual characteristics of each of the affected
trademarks.223 However, Australia countered that
[T]he fact that trademarks are ordinarily acquired, registered, and
enforced on an individual basis is simply a consequence of the fact
that trademarks must be capable of distinguishing between
products in the course of trade. It does not follow that any
justification for the imposition of special requirements upon the
use of a trademark must likewise be framed by reference to the
characteristics of individual trademarks.224

Australia also rebutted complainants’ claims by arguing that
they mischaracterized how TPP measures are designed to
operate.225 The premise of the TPP measure is not that the
trademarks increase the appeal of tobacco or decrease health
warnings. Rather, the premise is that TPP will minimize the
ability of tobacco packages to have these effects.226 The objective
is to “eliminate the opportunity for tobacco companies to use the
package as a medium for advertising and promoting the
product.”227
Australia made the compelling claim that the complainants
adopted an “‘extreme evidentiary approach to public health
policymaking’.”228 Within this approach, Australia would be
220
221
222
223
224
225
226
227
228

Id. ¶ 7.2446.
Id. ¶ 7.2449.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2450.
Id. ¶ 7.2450.
Id. ¶ 7.2468.
Id. ¶ 7.2475.
Id.
Id. ¶ 7.2475.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2474.
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required to individually assess “each element of each trademark
for each of the many hundreds of tobacco and cigar packages that
were on the market in Australia prior to the implementation of
tobacco plain packaging.”229 Additionally, Australia relied on
the interpretation of TRIPS Article 17 in EC- Trademarks and
Geographical Indications (US) where the panel concluded that
there was “nothing in the text of Article 17 [that] indicate[d] that
a case-by-case analysis is . . . require[d] under the TRIPS
Agreement.”230
As a starting point, the panel referenced the text of Article
20, noting that the language does not address whether “special
requirements” refers to individual trademarks or a class of
trademarks or use of a trademark in a particular situation.231
Providing many examples, the panel concluded “that the use of
th[e] term [‘a trademark’] in the singular is a drafting convention
used in many provisions of the TRIPS Agreement and . . . [does
not imply] . . . that the justifiability of any special requirements
must be assessed in respect of each individual trademark.”232
The panel agreed with the complainants “that trademarks are
acquired, registered, maintained, invalidated and enforced on an
individual basis”233 and “that decisions on eligibility for
protection, registration and invalidation are taken in respect of
individual trademarks.”234 However, the panel makes the
critical distinction that Article 20 governs trademark use and
has no bearing on the eligibility for registration, invalidation of
trademarks, etc.235
On this issue, the panel found in favor of Australia,
reasoning that “Article 20 does not require the unjustifiability of
special requirements under Article 20 to be in all cases assessed
by a Member in respect of individual trademarks and their
specific features.”236 The panel believed Australia’s stated
229
230
231
232
233
234
235
236

Id. ¶ 7.2474.
Id. ¶ 7.2460.
Id. ¶ 7.2492.
Id. ¶ 7.2494.
Id. ¶ 7.2497.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2498.
Id. ¶ 7.2498.
Id. ¶ 7.2505.
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rationale for TPP measures and decided that Australia’s
approach—that prescribing a standardized, plain appearance
for tobacco packages and products is intended to minimize the
ability of tobacco packages and products to increase the appeal
of tobacco products—detracts from the effectiveness of graphic
health warnings, or mislead consumers as to the harms of
tobacco use. They noted that the approach is not, per se,
unjustifiable. Rather, to the extent that the requirements at
issue relate to an entire class of marks or signs, an assessment
of their unjustifiability is best approached in terms of the extent
to which this is supported by the reasons for their adoption.237
Third, Indonesia argued that TPP measures are
unjustifiable because Australia failed to follow its own process
in adopting them. Indonesia argues—independently of any
other complainant—that the TPP measures “unjustifiably
encumber the use of trademarks in the course of trade because
Australia had failed to follow its own process in adopting plain
packaging.”238 Indonesia advanced that “one of the definitions
for ‘justified’ is ‘to show sufficient lawful reason for an act
done’.”239 Indonesia argued that Australia failed to follow its
own regulatory procedures in passing TPP measures, and those
regulatory procedures were designed to determine, inter alia,
whether the proposed TPP measures were “justified.”240
Australia first counterargued that “it fully adhered to its
own internal administrative and legislative processes in
developing the TPP measures.”241 Australia’s next counterpoint
was that whether Australia adhered to its own internal
processes is “legally irrelevant to the interpretation and
application of Article 20.”242 Australia argued that adherence to
domestic law is not relevant because the term “‘unjustifiable’
turns on an objective rationale for special requirements [of a
trademark].”243
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Again, the panel largely agreed with Australia on this point.
Although the panel stated that it is possible that:
[T]he manner in which a measure was prepared and adopted may
inform the assessment of the unjustifiability of specific “special
requirements” under that standard[,] . . . Article 20 does not
impose any specific independent obligation on Members as to how
they should design their domestic legislative procedures or how
those procedures should operate. A Member’s compliance with its
own domestic regulatory procedures does not, in itself, determine
whether a Member has complied with its obligations under Article
20.244

Fourth, Cuba argued the TPP measures fall within the
illustrative list of measures in the first sentence of Article 20 and
are therefore presumptively invalid. The first sentence of TRIPS
Article 20 incorporates examples which Cuba claimed are
illustrative of trademark restrictions presumed to be
unjustifiable.245 In relevant part, Article 20 states:
The use of a trademark in the course of trade shall not be
unjustifiably encumbered by special requirements, such as use
with another trademark, use in a special form or use in a manner
detrimental to its capability to distinguish the goods or services of
one undertaking from those of other undertakings. 246

The panel agreed with Australia that the examples are
illustrative of special requirements, not examples of
encumbrances that are unjustifiable.247
c. Whether use of a trademark in the course of trade is being
“unjustifiably” encumbered by special requirements
Having determined that TPP measures relate to special
requirements that encumber trademarks in the course of trade,
and that those encumbrances are not per se unjustifiable, the
final issue for the panel to resolve in the Article 20 portion of
244
245
246
247
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their decision is whether TPP measures constitute an
unjustifiable encumbrance. In so doing, the panel applied the 3part test articulated previously in its decision and noted the
need to weigh and balance different interests at issue on a caseby-case basis.248 The three-part test is as follows:
a. the nature and extent of the encumbrance resulting from
the special requirements, bearing in mind the legitimate interest
of the trademark owner in using its trademark in the course of
trade and thereby allowing the trademark to fulfil its intended
function;
b. the reasons for which the special requirements are
applied, including any societal interests they are intended to
safeguard; and
c. whether these reasons provide sufficient support for the
resulting encumbrance.249

i. Nature and extent of the encumbrance
In considering the first factor, the panel considered the
implications that the constraints have in the marketplace, both
on (i) a trademark’s ability to distinguish goods and services in
the course of trade, and (ii) on a trademark owner’s ability to
extract economic value from the use of its trademark.250
Arguments presented by the parties on this issue go to the
ess
ential purpose of trademarks and to the core of the
protectable interests trademark law is designed to serve. It also
raises the interesting question of whether a trademark is itself
a form of advertising and/or promotion. Speaking broadly,
complainants focused on the complexity of figurative aspects of
trademarks and the message conveyed to consumers regarding
branding. For example, the Dominican Republic argued:
For consumer goods, branding plays a critical role in promoting
difference in the marketplace. Consumers are usually willing to
pay a premium for this guarantee of the quality, characteristics
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and reputation of the product. By distinguishing goods and
services in the marketplace, and by signaling quality,
characteristics, and reputation to consumers, trademarks create
valuable competitive opportunities for producers and exporting
countries.251

The panel summed up these arguments best:
The complainants have not sought to demonstrate that consumers
have in fact been unable to distinguish the commercial source of
tobacco products of one undertaking from those of other
undertakings . . . as a result of the TPP trademark requirements.
However, . . . they argue that the removal of figurative elements
has undermined the ability of trademarks to signal individual
tobacco products’ quality, characteristics and reputation to
consumers.252

Australia focused more narrowly on the classic definition of
trademark as an identifier of the source of a product or service.
For example, Australia argued that TPP measures still permit
tobacco manufacturers to distinguish their products from those
of others by allowing them to use company and brand name on
tobacco retail packaging.253
TPP measures restrict the
promotional function of trademarks by prohibiting the colors,
logos, etc.254 and eliminate the use of the package for advertising,
promoting, and conveying positive associations.255 However,
this is consistent with FCTC Guidelines Article 13.256 In
Australia’s view, TPP measures allow tobacco companies to
identify and distinguish the product’s source in order for
consumers to expect consistent quality when buying products
with the same trademark257 and do not impede the use of
trademarks to convey information about the product’s
characteristics. Essentially, the “quality function” is closely
Id. ¶ 7.2537.
Id. ¶ 7.2564.
253 Australia Trademarks Panel Report, supra note 4, ¶ 7.2541.
254 Id.
255 Id.
256 WHO FCTC, supra note 14, art.13 (“Each Party shall, in accordance
with its constitution or constitutional principles, undertake a comprehensive
ban of all tobacco advertising, promotion and sponsorship.”)
257 Australia Trademarks Panel Report, supra note 4, ¶ 7.2544.
251
252
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related to the “source identification function.” TPP measures “do
not impair the communication of the product’s quality,
characteristics and reputation as regards consistency of
experience and actual characteristics . . . TPP measures are
intended precisely to reduce the opportunities to signal artificial
perceptions and attitudinal characteristics or reputations, which
Australia characterizes as an ‘advertising function’.”258
Honduras, Cuba, and the Dominican Republic offered three
differing perspectives on the role of trademarks beyond source
identification. Honduras asserted, essentially, that trademarks
on tobacco products in Australia are not advertisements, and
that whether trademarks are used for advertising depends on
context. Trademarks can be used in advertising, but “that does
not mean that . . . trademarks are used for advertising in
Australia because advertising has not been allowed for tobacco
products in nearly the last 25 years.”259 Interestingly, Cuba
argued that trademarks on tobacco products in Australia are a
form of promotion stating that “[t]he manufacturers of prestige
and luxury goods would not commit very substantial funds to
marketing and global promotion of their trademarks if they
would simply serve to identify a producer.”260 The Dominican
Republic viewed the distinguishing features of trademark as
placed on a spectrum.261
Each additional feature adds
distinctive means for consumers to differentiate, and taking
away each additional feature decreases distinguishing power.262
Specifically:
The removal of these differentiating features means that the
relevant quality, characteristics, and reputation are not
adequately communicated to consumers, as they would be absent
the TPP measures. . . . [T]he TPP measures have led to
downtrading from higher- to low-priced tobacco products, which
shows that the distinctions between brands have weakened,
consumer loyalty has lessened, and switching between brands has

258
259
260
261
262

Id. ¶ 7.2565.
Id. ¶ 7.2547.
Id. ¶ 7.2549.
Id. ¶ 7.2552.
Id.

47

294

Australia’s Tobacco Plain Packaging Law

Vol. 32:2

increased.263
i. Trademark’s ability to distinguish goods
and services in course of trade versus other
trademark uses

The panel began by acknowledging that the effects of TPP
measures are “far-reaching” insofar as they “eliminate the
possibility of applying figurative trademarks, or figurative or
stylized elements of composite and word marks to tobacco retail
packaging and products, to distinguish the goods of one
undertaking . . . from those of [an]other.”264 As precedent, the
panel referenced EC – Trademarks and Geographical
Indications and noted that, although the case dealt with Article
17, it “provides useful contextual guidance as regards the
legitimacy of concerns about constraints on the use of
trademarks also for purposes of Article 20.”265 The panel in EC
– Trademarks and Geographical Indications stated:
Every trademark owner has a legitimate interest in preserving the
distinctiveness, or capacity to distinguish, of its trademark so that
it can perform that function. This includes its interest in using its
own trademark in connection with the relevant goods and services
of its own and authorized undertakings. Taking account of that
legitimate interest will also take account of the trademark owner’s
interest in the economic value of its mark arising from the
reputation that it enjoys and the quality that it denotes. 266

The panel then acknowledged that under Article 20, use in the
course of trade is not limited to a particular function of
trademarks.267 In fact, the panel specifically declined conflating
actual trademark use with different functions, and instead,
focuses on “the implications of the TPP trademark requirements
on a trademark’s ability to distinguish goods and services . . .
and on the ways in which a trademark owner might wish to use
its trademark in the marketplace, as well as how these
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requirements affect consumers.”268 It is important to recognize
the trademark owner’s interest in using the trademark for these
various purposes,269 and TPP’s impact of TPP on such uses.
Interestingly, the panel said: “[w]e also recognize that the
impact of these measures may vary between the different
purposes for which the right holder may wish to use its
trademark.”270
As to the purpose of a trademark as identifier of the source
of the product, “[t]he complainants have not sought to
demonstrate that consumers have in fact been unable to
distinguish the commercial source of tobacco products of one
undertaking from those of other undertakings . . . as a result of
the TPP trademark requirements,”271 as they are still permitted
to use company, brand, and variant names on retail tobacco
packaging.
On the essential question of whether trademarks on tobacco
packaging constitutes advertising and/or promotion, the panel
concluded that:
[B]randed packaging can act as an advertising or promotion tool
in relation to tobacco products, and . . . this has . . . been
considered to be the case by tobacco companies operating in the
Australian market, even in the presence of significant restrictions
on advertising [and] . . . particularly . . . in a regulatory context
such as Australia’s, where all other forms of advertising and
promotion for tobacco products are prohibited.272

Citing experts, the panel recognized that “a key purpose of the
use of branding on tobacco products, including packaging, is to
generate certain positive perceptions in relation to the product
in the eyes of the consumer.”273 To quote one expert report
submitted by the complainants, “trademarked packaging is the
only remaining communication vehicle for cigarette
268
269
270
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272
273
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manufacturers in Australia, where advertising and promotional
opportunities have been progressively reduced.”274 However,
Australia advances that the very purpose of the TPP measures
is “to prevent such design features from creating positive
product perceptions and thus to discourage the use of tobacco
products by consumers.”275 This debate over the permissibility
of trademark usage beyond product source identification and
extending to product advertisement and/or promotion is at the
core of this issue.
The panel acknowledged the impact of TPP on the use and
value of creating and maintaining brand differentiation in a few
significant ways. One expert noted that “the benefits that a
strong brand provides to the firm . . . include greater customer
loyalty, higher margins and ease of international expansion.”276
Additionally, the value of a strong brand is especially high for a
product like cigarettes since brands are key sources of
differentiation among otherwise largely similar products.277 The
panel noted that
[B]y disallowing the use of design features of trademarks, the TPP
measures prevent a trademark owner from using such features to
convey any messages about the product . . . and deriving any
economic value from the use of such features. Therefore, the TPP
measures prevent a trademark owner from extracting economic
value from any design features of its trademark through its use in
the course of trade.278

But despite that powerful acknowledgment, the panel decided
this issue in Australia’s favor. In doing so, it ultimately rested
its rationale on two points: (i) “[t]he practical implications of
those prohibitions are partly mitigated by the fact that the TPP
measures allow tobacco manufacturers to use word trademarks,
including brand and variant names, to distinguish their
products from each other[;]”279 and (ii) there is no evidence that
274
275
276
277
278
279

Id. ¶ 7.2568.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2567.
Id. ¶ 7.2568.
Id. ¶ 7.2568.
Id. ¶ 7.2569.
Id. ¶ 7.2570.

https://digitalcommons.pace.edu/pilr/vol32/iss2/2

50

2020

PACE INT’L L. REV.

297

consumers have been unable to distinguish between tobacco
products.280
ii. Trademark owner’s ability to extract
economic value from the use of its
trademark

The complainants argued that by restricting the
opportunity for product differentiation, TPP measures “increase
price competition and adversely impact in particular premium
brands.”281 Previously in their opinion, the panel analyzed
evidence on the impact of reduced differentiation on prices and
on downward substitution.282 On the issue of price competition,
empirical evidence submitted by both Australia and the
complainants showed that the net of taxes price of tobacco
products has increased since the introduction of the TPP
measures, with higher-priced brands maintaining their pricing
premiums.283 Moreover, in the period from Q4 2009 to Q3 2013,
even though tobacco product consumption decreased, the total
value of the retail market increased.284 The panel concluded:
Overall, the empirical evidence before us relating to cigarette
prices, to the total value of the retail market and to the total value
and volume of cigarette imports does not validate the
complainants’ argument that the TPP measures will lead to an
increase in price competition and a fall in prices, and consequently
to a decrease in the sales value of tobacco products and the total
value of imports.285

Lastly, although the panel found some limited evidence that the
TPP measures appear to have had a negative impact on the ratio
of higher- to low-priced cigarette wholesale sales, the panel was
“not persuaded . . . that this decrease in the consumption and
imports of premium tobacco products is exclusively the result of
‘downtrading’ . . . i.e. a transfer of consumption/imports from
premium to non-premium products.”286
280
281
282
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ii. Reasons for which the special requirements are applied,
including any societal interests they are intended to safeguard
Australia provided extensive evidence for the reasons it
undertook TPP measures. It cited WHO statistics that “[t]obacco
use is responsible for the deaths of nearly 6,000,000 people
annually, including 600,000 non-smokers exposed to secondhand smoke.”287 It pointed out that there is no safe level of
tobacco usage—tobacco use harms nearly every organ in the
body; nicotine is highly addictive; cigarettes are particularly
effective in delivering nicotine; tobacco is a unique, highly
addictive, and deadly product; and tobacco is “the only legal
consumer product that kills half of its long-term users when
used exactly as intended by the manufacturer.”288 Importantly,
Australia noted that “[t]his decision was made in the context of
the comprehensive range of Australian tobacco control
measures, including advertising and promotional bans, excise
measures, graphic health warnings, and investment in antismoking initiatives,”289 a point the panel reiterated in its
decision.290 None of the complainants disputed whether smoking
is dangerous,291 and Honduras claimed that the dispute “is not
about whether smoking is dangerous or whether it affects the
health of many people in Australia and around the world—it is
and it does.”292 (The other three complainants also espoused the
importance of public health).293 Rather, “[i]n Honduras’ view,
‘[t]he issue before the panel is whether the simple invocation of
the protection of public health, without more, provides a
sufficient basis for a Member to disregard its binding
multilateral commitments’.”294

Australia Trademarks Panel Report, supra note 4, ¶ 7.2576.
Id. ¶ 7.2578.
289 Id. ¶ 7.2581.
290 Id. ¶ 7.2586.
291 See id. ¶¶ 7.2582–7.2585 (discussing that Honduras, the Dominican
Republic, Cuba and Indonesia all recognized in the dispute, to one degree or
another, the dangers of smoking tobacco and the importance of governmental
public health initiatives).
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The panel determined that the reasons supporting
Australia’s passage and implementation of TPP measures are to
improve public health by reducing the use of and exposure to
tobacco products. These measures are part of a larger strategic
plan involving “advertising and promotional bans, excise taxes,
GWHs [graphic health warnings] and investments in antismoking initiatives.”295 As noted above, the parties agreed about
the priority of public health and the importance of effective
tobacco control measures.296 The panel also pointed to WTO
members’ emphasis on the importance of public health as a
legitimate policy concern under paragraph 4 of the Doha
Declaration.297
ii. Whether these reasons provide sufficient support for the
resulting encumbrance
To begin answering this central question, the panel noted
that it must first “assess the public health concerns that underlie
the TPP trademark requirements against their implications on
the use of trademarks in the course of trade, taking into account
the nature and extent of the encumbrances at issue.”298
The parties did not dispute that the grounds on which the
special requirements are applied under TPP address an
“exceptionally grave domestic and global health problem
involving a high level of preventable morbidity and mortality.”299
These special requirements, in conjunction with the overall TPP
and tobacco-control measures, “are capable of contributing, and
do in fact contribute, to Australia’s objective of improving public
health by reducing the use of, and exposure to, tobacco
products.”300 In the panel’s view, this suggested that the reasons
for the application of the trademark requirements provided
sufficient support for the resulting encumbrances and that TPP
measures are not applied unjustifiably in this case.301 The
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removal of design features on cigarette packaging “is apt to
reduce the appeal of tobacco products and increase the
effectiveness of GHWs [graphic health warnings]. It is integral
to this approach that the use of certain figurative features and
signs . . . is restricted as part of the overall standardization of
retail packaging”302 and “the uniformity of these features is also
an integral part of the approach underlying the TPP
measures.”303 The panel next noted that:
[T]he importance of the public health reasons for which the
trademark-related special requirements under the TPP measures
are applied is further underscored by the fact that Australia
pursues its domestic public health objective in line with its
commitments under the FCTC, which “was developed in response
to the globalization of the tobacco epidemic” and has been ratified
by 180 countries.304

The panel rejected the complainants’ proposal to analyze
alternative measures.305 Complainants suggested alternative
measures, but the panel concluded that they had not shown that
any of the proposed alternatives would be better in contributing
to Australia’s public health objective or that proposed
alternatives call into question the sufficiency of the reasons
Australia advanced in support of its TPP restrictions.306 In
particular, “[the panel] observed that any pre-vetting
mechanism would involve the introduction of administrative
discretion and the possibility of permitting tobacco packaging
elements that would have impacts that are contrary to the TPP
measures’ objective.”307
On the issue of the need for examination of alternative
measures, the panel carefully laid out a middle ground. On one
hand, it provided some scope of policy making flexibility and
control widely recognized as fundamental for a sovereign state.
The panel interpreted the term “unjustifiably” in Article 20 to
302
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provide “a degree of latitude to a Member to choose an
intervention to address a policy objective, which may . . .
impact . . . the use of trademarks in the course of trade, as long
as the reasons sufficiently support any resulting
encumbrance.”308 However, the panel also noted that inquiry of
alternative measures is in fact relevant to the issue of
justifiability. The panel stated that it is:
[N]ot exclud[ing] the possibility that the availability of an
alternative measure could, in . . . a particular case, call into
question the reasons a respondent would have given for the
adoption of a measure challenged under Article 20. This might be
the case . . . if a readily available alternative would lead to at least
equivalent outcomes in terms of the policy objective of the
challenged measure, thus calling into question whether the stated
reasons sufficiently support any encumbrances on the use of
trademarks resulting from the measure.309

To conclude, the panel acknowledged that trademarks have
substantial economic value and that special requirements are
far-reaching in terms of trademark owners’ opportunities to
extract economic value from the use of figurative or stylized
trademark features.310 In light of that recognition, the panel’s
rationales for concluding that TPP measures are not an
unjustifiable encumbrance on special trademark requirements
in the course of trade, and therefore not a violation of Article
20,311 consist of the following: first, the gravity of the tobacco
control issue is an “exceptionally grave domestic and global
health problem,”312 a point that was both uncontested and amply
supported; second, there is demonstrative value of the TPP
measures insofar as, in conjunction with the rest of Australia’s
tobacco control plan, the measures have helped fulfill public
health objectives;313 third, TPP is an integral part of
comprehensive tobacco control policies;314 fourth, Australia has
308
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pursued its public health objectives in line with emerging
multilateral public health policies as reflected by FCTC;315 fifth,
the panel rejected complainants’ argument that individual
trademark features must be individually assessed under Article
20;316 and sixth, the panel rejected complainants’ argument that
alternative measures preclude a finding of justifiability and that
a pre-vetting mechanism should have been introduced.317
III. CONCLUSIONS AND FURTHER EXPLORATION
On July 19, 2018, Honduras appealed the Panel Report to
the Appellate Body.318 As of this writing, no announcement has
been made regarding the expected timing of the Appellate Body’s
forthcoming report. In the meantime, there are several lessons
to glean from the Panel Report decision and the progress of the
case so far. First, the importance of this case—its outcome, the
panel’s rationale, and legal and business implications—is hard
to overstate.
According to Professor Daniel Gervais of
Vanderbilt Law School, who was interviewed for a 2013 Forbes
article, “[t]his is the ‘first TRIPS debate on the intersection
between trademarks and health . . . [and] [i]t’s a huge precedent
to set no matter how you cut it.”319 Based on the panel report in
the case so far, here are some preliminary conclusions and
potential legal and business implications.
A. Legal Conclusions and Implications
1. New guidance on important legal issues
In its report, the panel articulated a number of legal
principles which, if upheld by the Appellate Body, will provide
important guidance in future cases involving challenges
Id. ¶ 7.2504.
Id. ¶ 7.2603.
317 Australia Trademarks Panel Report, supra note 4, ¶ 7.2603.
318 Honduras files appeal against WTO panel ruling on tobacco plain
packaging requirements, WORLD TRADE ORG., (July 19, 2018),
https://www.wto.org/english/news_e/news18_e/ds435apl_19jul18_e.htm.
319 Daniel Fisher, Will Australia’s Gruesome Cigarette Warnings Show Up
on Soda and Potato Chips Next? FORBES (Sept. 5, 2013, 1:56 PM),
https://www.forbes.com/sites/danielfisher/2013/09/05/will-australiasgruesome-cigarette-warnings-show-up-on-soda-and-potato-chipsnext/#55d486e23cd6.
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involving TRIPS Article 20 and other TRIPS provisions. The
following are of particular note.
a. Burden of Proof for justifiability element
Not surprisingly, the panel stated that “it is for the
complainants to present a prima facie case that the TPP
measures amount to special requirements and that the use of a
trademark in the course of trade is unjustifiably encumbered by
these requirements.”320 Of note is the panel’s rejection of the
complainants’ claim to the contrary in deciding that the burden
of proof rested with the complainants for the element of
justifiability.
b. per se unjustifiable
Also significant is the panel’s opinion regarding
complainants’ claims that Australia’s TPP measures are per se
unjustifiable. First, the extreme nature of the encumbrance’s
restrictiveness is not, in and of itself, enough to render the
encumbrance per se unjustifiable.321 However, the fact that
Australia could advance any rational connection at all to support
TPP measures is not sufficient to eliminate an inquiry on per se
unjustifiability. Even where the rational connection exists, the
panel must still inquire as to whether the special requirements
that encumber the trademark in the course of trade are per se
unjustifiable.322 Second, and perhaps most critically, the panel
rejected complainants’ argument that Australia should have
separately considered each individual design feature of a
trademark, such as typeface, size, and color.323 An opposing
decision on this point could have been insurmountable for
Australia. The panel determined that “Article 20 does not
require the unjustifiability of special requirements . . . to be in
all cases assessed by a Member in respect of individual
trademarks and their specific features.”324 Third, although the
panel stated that the way in which measures are domestically
designed and adopted can inform the assessment of
320
321
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unjustifiability of specific special requirements, it also stated
that Article 20:
[D]oes not impose any specific independent obligation on Members
as to how they should design their domestic legislative procedures
or how those procedures should operate. A Member’s compliance
with its own domestic regulatory procedures does not, in itself,
determine whether a Member has complied with its obligations
under Article 20.325

This respects Members’ sovereign decision-making processes
and policy development, yet it also recognizes that adherence to
domestic rules cannot serve as a thinly-veiled bad faith
argument. Last, the language of TRIPS Article 20 incorporates
examples of special requirements, not examples of
encumbrances that are unjustifiable.326
c. test for justifiability
The formulation of a test for justifiability was the key issue
in the Article 20 portion of the panel’s decision, and arguably the
most important legal question resolved in the entire 888 page
panel report. Writing prior to the panel decision, Professor
Mitchell stated, “[t]he concept of ‘justifiability’ under Article 20
is ambiguous and has not been considered in any WTO
jurisprudence.”327 Although Dispute Panels and the Appellate
Bodies have considered the meaning of “unjustifiable” in other
contexts, no prior report or decision has considered the meaning
of “unjustifiable” in the context of Article 20.328 The panel
articulated that these factors to consider in the determination of
whether the special requirements that encumber trademarks
violate Article 20: (a) nature and extent of the encumbrance; (b)
reasons for the special requirement; and (c) whether the reasons
provide sufficient support for the encumbrance.329
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d. Whether the Panel must consider alternative measures
Should alternative measures that could have been deployed
be considered? Does it matter whether alternative measures
could have made an equivalent contribution while imposing less
or no encumbrance? While providing “a degree of latitude to a
Member to choose an intervention to address a policy
objective . . . as long as the reasons sufficiently support any
resulting encumbrance[,]”330 the panel also noted that inquiry of
alternative measures is in fact relevant to the issue of
justifiability.331 Interestingly, the panel appeared to be deciding
that the relevance of alternative measures would help preclude
questionable or bad faith claims of justifiability, stating that
“the availability of an alternative measure could, in . . . a
particular case, call into question the reasons a respondent
would have given for the adoption of a measure challenged under
Article 20.”332
2. Critical nature of justifiability element
While legal analysis can hardly be reduced to a scorecard, it
is worthwhile to note that of the five Article 20 elements the
panel identified (special requirements, encumbrance, course of
trade, use of trademark and unjustifiably), Australia “lost”
four.333 And yet, the panel decided that Australia was not in
violation of Article 20 in enacting TPP measures.
One
implication is just how much of the case turned on issue of
proving justifiability of trademark special requirements.
3. Do Australia’s TPP measures work? Is the measures’
effectiveness relevant to the question of justifiability?
There is good news on this front. At least to some extent,
TPP measures work. As mentioned, the law became effective
December 1, 2012. According to the Government of Australia’s
Post-Implementation Review of Plain Packaging 2016 [PIR]:

330
331
332
333

Id. ¶ 7.2598.
Id.
Id.
Id. ¶¶ 7.2145, 7.2146.
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The major relevant datasets all show drops in national prevalence
rates since 2012. For example, data from Roy Morgan Research,
the [Australian Bureau of Statistics] and [Australian Institute of
Health and Welfare] relating to tobacco prevalence, as well as data
relating to tobacco excise and duty clearances, and household
expenditure, all show continuing declines in recent years. Dr[.]
[Tasneem] Chipty’s modelling also estimated a 0.55 percentage
point drop in smoking prevalence in Australia, over 34 months
following implementation, attributable to the 2012 packaging
changes. This strong result, that is “likely understated”, is
expected to grow into the future as the full effects of the 2012
packaging changes are reali[z]ed over the longer term.334

According to the WHO, the referenced .55% fall in smoking
equates to more than 108,000 people quitting, not relapsing or
not starting to smoke during that period.335 The PIR concluded
that “[i]n light of all of the above, it is the conclusion of this PIR
that the measure has begun to achieve its public health
objectives of reducing smoking and exposure to tobacco smoke in
Australia and it is expected to continue to do so into the
future.”336
Some have argued, prior to the release of the panel decision,
that the strength of evidence as to whether and the extent to
which plain packaging effectively reduces tobacco consumption
is “likely to be central to the interpretation of what amounts to
an unjustified encumbrance under TRIPS Agreement Article
20.”337 While perhaps not “central,” the panel report does note
that TPP measures “are capable of contributing, and do in fact
contribute, to Australia’s objective of improving public health by
reducing use of, and exposure to, tobacco products.”338 In the
panel’s view, this suggested that the reasons for the application
of the trademark requirements provide sufficient support for the
resulting encumbrances.339
334 Austl. Gov’t Dep’t of Health, Post-Implementation Review - Tobacco
Plain
Packaging
2016,
57,
https://ris.pmc.gov.au/sites/default/files/
posts/2016/02/Tobacco-Plain-Packaging-PIR.pdf [hereinafter Austl. PIR].
335 WHO World No Tobacco Day, supra note 6.
336 Austl. PIR, supra note 334, at 57.
337 Frankel & Gervais, supra note 45, at 1166.
338 Australia Trademarks Panel Report, supra note 4, at ¶ 7.2592.
339 Id.
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While proof of the effectiveness of plain packaging could
justify the encumbrance resulting from special trademark
requirements, proof that it does not work should not require a
finding that the encumbrance is not justified. Requiring
governments to prove the efficacy of yet-to-be-implemented or
newly-implemented policy measures to show justification of
special requirements would be crippling. This could result in
less innovation, greater burden, and more restraint and
hesitancy
in
undertaking
policy-making
initiatives.
Governments cannot always accurately predict outcomes before
launching a new initiative, especially when being the first
country to do so. Thus, governments should not be required to
successfully fulfill their objectives. Moreover, efficacy can be
difficult or impossible to measure. Some markers of success
cannot be proven because they cannot be known. Who knows
whether tobacco sellers would have engaged in new,
sophisticated marketing that would have increased tobacco
usage but for TPP measures? More importantly, such an
approach would burden the policymaking that is the
responsibility of sovereign governments, particularly as regards
critical issues like public health. In short, efficacy of the special
requirements is relevant to an analysis of justification, but proof
of success should not be essential.
B. Slippery slope?
Some have warned that regulation similar to Australia’s
TPP measures could apply to a number of consumer products
such as alcohol, or fatty, sugary or salty foods. The case has even
spawned alarmist claims that “global-warming regulators could
decide gasoline refiners are encouraging excessive driving with
their ads”340 and musings aloud as to “whether Bloombergian
anti-obesity crusaders, say, could require pictures of diabetesravaged feet on cans of soda or morbidly obese patients on bags
of potato chips.”341 Which product(s) could be next? Could plain
packaging and similar advertising restrictions be extended to
non-food products which could cause harm if misused, such as
340 See, e.g., Fisher, supra note 319 (discussing the possibility of future
WTO controls).
341 Id.
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pharmaceuticals or insecticide or construction equipment?
A full analysis is beyond the scope of this article, but the
panel report in the Australia trademarks case informs the
inquiry, frames relevant questions and enables some general
predictions. Obviously, any Article 20 evaluation of trademark
special requirements depends on the specific encumbrance and
circumstances. Without this information, no one can answer
questions about which consumer product packaging policymaking and rules can successfully be defended in an Article 20
challenge. However, here are a few general observations.
The panel in the case focused in large part on the following
three points. Application of these to other unhealthy food
products can help evaluate how close a similar trademark
restriction scheme would map to the TPP Article 20 challenge.
First, they focused on the tobacco control issue, stating that
it is an “exceptionally grave domestic and global health
problem,”342 a point that was both uncontested and amply
supported. Alcohol is also a serious problem worldwide.
Globally, there were about 3.3 million deaths in 2012 (5.9% of all
global deaths) attributable to alcohol consumption.343 Of course,
there are numerous severe social and economic consequences
beyond this.344 Unhealthy foods such as sugary and salty
foods345 contribute to rising obesity levels,346 which in turn cause
a host of health and related problems. The similarities and
differences of the medical and health effects of these products as
compared to tobacco usage would be an important consideration.
Australia Trademarks Panel Report, supra note 4, ¶ 7.2592.
WORLD HEALTH ORG., GLOBAL STATUS REPORT ON ALCOHOL AND HEALTH
2014 vii (2014).
344 See generally id. 11–16 (discussing major disease and injury categories
causally impacted by alcohol consumption).
345 See, e.g., Public health takes aim at sugar and salt, HARV. SCH. PUB.
HEALTH NEWS (2009), https://www.hsph.harvard.edu/news/magazine/sugarand-salt/ (discussing research at the Harvard School of Public Health and
elsewhere finding a connection with sugary drinks to an epidemic of obesity in
the United States).
346 Id. (citing Obesity Rate Soars in American Adults and Youth, HARV.
SCH. PUB. HEALTH NEWS (2017), https://www.hsph.harvard.edu/news/hsph-inthe-news/obesity-american-adults-youth/).
342
343

https://digitalcommons.pace.edu/pilr/vol32/iss2/2

62

2020

PACE INT’L L. REV.

309

Second, they focused on how TPP is an integral part of
comprehensive tobacco control policies.347 TPP measures were
taken as part of a much larger strategy involving many other
initiatives. While governments do take measures to control or
discourage alcohol consumption, such as the imposition of excise
taxes, it would be important to evaluate how comprehensive the
measures are, how well enforced they are, etc. Salty, fatty, and
sugary foods probably have weaker government disincentive
measures.
Third, they focused on how, in part, Australia pursued its
public health objectives in line with emerging multilateral
public health policies, especially FCTC.348 The panel stated that
in part, the strength of Australia’s justifiability claim is that it
clearly was adopting TPP measures to give effect to its
obligations under FCTC.349 There is no international convention
as yet for control of alcohol consumption, although a Framework
Convention on Alcohol Control, similar to the FCTC, has
periodically been suggested350 and the WHO in 2010 released a
Global Strategy to Reduce the Harmful Use of Alcohol.351 No
country, therefore, could argue that alcohol packaging
legislation gives effect to worldwide convention obligations
similar to the FCTC. While the WHO has studied the effects of
marketing sugary, fatty, and salty foods, especially on
children,352 like alcohol, there is no sweeping international
Australia Trademarks Panel Report, supra note 4, ¶ 7.2604.
Id. ¶ 7.2504.
349 Id. ¶ 7.243.
350 See, e.g., Shiu Lun Au Yeung & Tai Hing Lam, Unite for a Framework
Convention for Alcohol Control, 393 THE LANCET 1778, 1778–79 (2019)
(advocating for a Framework Convention for Alcohol Control based on the
success of the World Health Organization’s Framework Convention on Tobacco
Control); see also A Call for a Framework Convention on Alcohol Control, Am.
Pub. Health Ass’n (Nov. 8, 2006), https://www.apha.org/policies-andadvocacy/public-health-policy-statements/policy-database/2014/07/07/11/50/acall-for-a-framework-convention-on-alcohol-control
(calling
for
an
international coordinating mechanism similar to the Framework Convention
on Tobacco Control).
351 See generally WORLD HEALTH ORG., GLOBAL STRATEGY TO REDUCE THE
HARMFUL USE OF ALCOHOL (2010) (outlining the global strategy to reduce the
harmful use of alcohol endorsed by the World Health Organization in 2010).
352 See generally WORLD HEALTH ORG., MARKETING OF FOODS HIGH IN FAT,
SALT AND SUGAR TO CHILDREN: UPDATE 2012-2013 (2013) (providing
347
348
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convention on this subject, either.
There are other aspects of the inherent nature of tobacco
and tobacco control that factor into the comparisons with
unhealthy foods and alcohol. Tobacco’s inherent characteristics
distinguish it from these other products in some important ways.
For example, as Australia claimed in the case, tobacco is a
“uniquely hazardous product” because it is “the only lawful
consumer product that kills its users when used as intended”353
by the manufacturer, and because “[t]here is no safe level of
tobacco use or safe level of exposure to second-hand or
environmental tobacco smoke.”354 The same cannot be said of
alcohol or sugary, fatty or salty foods which, if consumed in
moderation, are not dangerous to the majority of the population.
Also, the addictive properties of these products are a significant
factor. Alcohol is addictive, and the extent to which unhealthy
foods are addictive will be an important factor.
The marketing, advertising, and promotion of these various
products also differs from tobacco in some significant and
relevant ways. From a logistical perspective, control on tobacco
packaging is much easier and more effective than analogous
control measures would be for sugary, fatty or salty foods.
Cigarettes are a single product, even though there are
classifications for flavored tobacco, etc. This makes it much
easier to identify and control the product, its packaging, and its
distribution. Sugar, in contrast, comes in many more forms, it
can be processed into a huge variety of foods and consequently,
packaging measures similar to TPP would be far more difficult
to craft and enforce. How, for example, could a country enact a
plain packaging-type statute that would cover sugary foods?
Would all foods above a certain sugar content level be required
to be packaged in drab labelling, devoid of logos and other design
trademarks? In Australia, one reason TPP measures were
effective is that virtually all other forms of advertising and
promotion for tobacco products are prohibited. There would be
little incentive to initiate plain packaging measures when there
information on the marketing of food and beverages to children over the course
of a decade).
353 Australia Trademarks Panel Report, supra note 4, ¶ 7.2476.
354 Id. ¶ 7.2576.
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are several other outlets for advertising, branding and
messaging, which would result in limited effectiveness of any
such measure.
C. Other implications for tobacco/smoking industry
Tobacco companies are turning their attention to less
developed countries as a result of declining smoking rates in
more developed countries.355 Further, Australia’s PIR found a
correlation between TPP measures and decreased tobacco use.356
Therefore, it could be argued that TPP measures have, in part,
caused tobacco companies to seek and exploit markets in less
developed countries. These countries may have weaker public
health systems and infrastructure, insufficient medical care
availability, fewer resources to devote to anti-smoking public
education campaigns, and other pressing competing policy
priorities.
That is not all. The tobacco industry is determined to fight
the case: “[b]ig tobacco has commissioned research that
contradicts the findings of the [Australian PIR] and is funding
the Dominican Republic’s legal challenge to plain packaging at
the World Trade Organisation.”357 Individual companies, of
course, cannot take a case directly to the WTO. Should they be
able to use a country as, essentially, a front for the legal
challenge?

See Anna Gilmore, Big tobacco targets the young in poor countries –
with deadly consequences, GUARDIAN (Dec. 1, 2015, 6:57 PM),
https://www.theguardian.com/global-development/2015/dec/01/big-tobaccoindustry-targets-young-people-poor-countries-smoking (noting that people in
low-income countries observe eighty-one times more tobacco advertisements
than those in high-income countries); see also Emily Savell et. al., The
Environmental Profile of a Community’s Health: A Cross-Sectional Study on
Tobacco Marketing in 16 Countries, WORLD HEALTH ORG. BULL. (2015)
(discussing the high frequency of tobacco related advertisements in low-income
countries).
356 See generally Post-Implementation Review: Tobacco Plain Packaging
2016, AUSTRALIA GOV. DEP’T OF HEALTH (2016), https://ris.pmc.gov.au/sites
/default/files/posts/2016/02/Tobacco-Plain-Packaging-PIR.pdf
(discussing
studies in which tobacco packaging decreased tobacco use).
357 Jamie Smyth, Australia Hails Plain Packaging on Tobacco, FIN. TIMES
(May
4,
2016),
https://www.ft.com/content/6248cfee-11e3-11e6-91da096d89bd2173.
355
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Since Australia’s implementation of TPP measures, several
others have followed or are considering similar legislation.
Australia, France, the United Kingdom, New Zealand, and
Norway were the first five countries to implement plain
packaging measures, all by July 2018.358 As of this writing,
Ireland, Thailand, Uruguay, Saudi Arabia, Slovenia, Turkey,
Israel, and Canada have also passed and implemented plain
packaging legislation.359 Singapore, Belgium and Hungary have
enacted plain packaging legislation that is due to take effect
soon.360
In conclusion, the drafters of the TRIPS Agreement
intended balance “between the existence of a legitimate interest
of trademark owners in using their trademarks in the
marketplace, and the right of WTO Members to adopt measures
for the protection of certain societal interests that may adversely
affect such use, including for public health reasons.”361 The
panel was in unqualified agreement with complainants that TPP
provisions relating to figurative/stylized elements of trademarks
are “far-reaching”362 and “prevent a trademark owner from
extracting economic value from any design features of its
trademark.”363
According to Philip Morris International’s
counsel in charge of regulatory policy, PMI “built enormous
value around those trademarks in full compliance with the law
and with the full blessing of the government . . . . Now the
government can take away such property without any decent
explanation, without looking at the circumstances, without even
358 Crawford Moodie et. al., Plain packaging: Legislative Differences in
Australia, France, the UK, New Zealand and Norway, and Options for
Strengthening Regulations, 28 TOBACCO CONTROL 485, 485 (2019).
359 Standardized
or
Plain
Tobacco
Packaging:
International
Developments, CAMPAIGN TOBACCO-FREE KIDS (Feb. 10, 2020), https://www.
tobaccofreekids.org/assets/global/pdfs/en/standardized_packaging_developme
nts_en.pdf.
360 Id.; see also WHO Report, supra note 8, at 80 (stating that in 2016
Hungary passed legislation requiring plain-packaging of tobacco products);
Canada becomes 14th country to adopt plain packaging laws, CANCER COUNCIL
VICTORIA (May
2,
2019),
https://www.cancervic.org.au/about/mediareleases/2019-media-releases/may-2019/canada-becomes-14th-country-toadopt-plain-packaging-laws.html (listing Hungary as one of several countries
to adopt plain packaging).
361 Australia Trademarks Panel Report, supra note 4, ¶ 7.2504.
362 Id. ¶ 7.2557.
363 Id. ¶ 7.2569.
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paying.”364 Clashing with these interests, the WHO asserts that
tobacco-related illnesses are some of the biggest public health
threats in the history of the world.365 In this case, the panel
found that TPP measures did not unjustifiably encumber
trademarks, prioritizing public health over branding. It remains
to be seen whether the Appellate Body will agree.

364
365

Fisher, supra note 319.
WHO World No Tobacco Day, supra note 6.
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